{
    "paper_id": "27dca7ca1495f0f0a868d4b3b76d7d8b8c19b625",
    "metadata": {
        "title": "A",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "clinical manifestations of, 1993 differential diagnosis for, 1984 eculizumab and, 282-283 epidemiology of, 1993 laboratory manifestations of, 1994 -1996 , 1996t overview of, 1984 pathobiology of, 1993 -1994 , 1994f-1995f prognosis for, 1996 therapy for, 1996 -1997 , 23 Aurora A kinase, 1359 , 1857 Autoantibodies. See also Autoimmunity; Self-tolerance immune thrombocytopenia purpura and, 1944-1945, 1945t patterns of in systemic autoimmune diseases, 290t posttransfusion purpura and, 1945t, 1953-1954 , 191-193 apoptosis and, 186-187, 190-191, 191f Basophils, 203, 331 Batroxobin, 1927 BAX, 190-193, 193f 4-1BB, T cell activation and, 226 B-cell Blood groups (Continued) Bone marrow failure syndromes, inherited (Continued) CD22, 1050 , 1052t, 1288 CD25, 228, 718 CD26, 1647 CD27, 226, 1421 -1422 CD28, 225-226, 226f, 288 CD3, 223-224 CD30, 1339 CD33, 321, 938-939, 991, 1154 , 1167 CD34, 299-300, 1129 -1131 , 1135 CD34+ hematopoietic stem cells anticoagulants and, 1526 apheresis and, 1524 -1526 , 1525b chemokines and, 1523-1524 chemotherapy plus cytokine mobilization, 1523 cytokine mobilization and, 1522 dendritic cell development and, 247-248 granulocyte colony-stimulating factors and, 1522-1523 granulocyte-macrophage colony-stimulating factor and, 1523 large-volume leukapheresis and, 1526-1527 mobilization of cells into peripheral blood, 1521-1523, 1522b overview of, 1521 patients difficult to mobilize and, 1524 pediatric donors and patients and, 1527 plerixafor and, 1524-1525 quantification of, 1529 timing of, 1524 -1525 CD35, 269-272, 271f CD36, 130, 130f, 130t, 2130 CD38, 1251 CD39, 1831 -1832 graft-versus-host disease and, 1655 -1656 HIV life cycle and, 2263 -2264 T cell development and, 224f, 228-229, 231 CD4+ T cells, 1666 , 1724 , 2266 -2267 CD4+Th cells, 231 CD40, 288, 715 CD40 ligand (CD40LG) deficiency, 715 CD43, 1154 CD44, 124, 130, 130t, 1154 CD45, 172, 173t, 1154 , 1268 CD47, 125 CD48, 1575 CD49d, 1251 CD49f+ human hematopoietic stem cells, 97-98 CD55, 417-418 CD56, 240, 241f, 241t, 1575 CD56 bright system and, [154] [155] 523, [851] [852] [853] 851f Cell death, 186, [194] [195] Checkpoint blockade therapies after hematopoietic stem cell transplantation, 1585 cytotoxic T lymphocyte-associated antigen-4 and, 1583, 1585-1586 future directions, 1586 overview of, 1583 programmed cell death protein 1 and, 1583 1 and, -1586 Chediak-Higashi syndrome 1 (CHS1) gene, 698 Chediak-Higashi syndrome (CHS), 335, 706, 706t, 719 Cheeses, 1458 Chelation therapy, 489, 489b, 554-555, 592, 964 Chemistry, Manufacturing, and Control (CMC), 1534 , 1542 Chemoimmunotherapy, 1255 -1256 , 1294 1384 3, 796, 796f 5, 793-794, 944, 952, 960, 960f, 964-965. See also Del(5q) 6, 825 7, 794, 952 11, 805, 806f, 824-825 13, 822, 830-831, 1384 17, 795, 825, 952, 1384 20, 952 21, 1017 -1018 , 1156 -1157 Cidofovir, 1455 Cilostazol, 1936 , 2165 CIP1. See P21 Circumcision, 2009 Cirrhosis, 1752 Cis-acting elements, defined, 9 Cisplatin, 860-861, 902 Cistrome, 20 Citrate, 1707 , 1851 , -1852 , , 1851f factor VIII and, 2003 , hemostasis and, 1834 , -1837 , , 1835f key events in, 1906 , , 1907f, 2035f laboratory evaluation of methodology, 1922 , physiology underlying, 1922 , , 1925f practical approach, 1926 , -1927 , , 1927t specific, 1925 , -1926 , 1978 -1979 , 1979t-1980t Danazol, 429 Dapsone, 671 Daratumumab, 1415 , 1979 -1980 , 1979t-1980t, 2178 -2179 for (D-ITP), 1961 (D-ITP), -1965 (D-ITP), , 1962f, 1963b lymphocytosis, 683 neutropenia, 679-680, 679t neutrophilia, 677 non-oxidative hemolysis, 669-670 oxidative hemolysis, 670-671, 671b platelet disorders, 1932-1939, 1933t prothrombin deficiency, 2040 thrombocytopenia autoimmune thrombocytopenia, 1965 differential diagnosis for, 2072 heparin-induced. See Heparin-induced thrombocytopenia immune, 1961-1965, 1963b, 1963t immune of rapid onset, 1965-1966 mechanisms of, 1962f miscellaneous syndromes, 1966-1967 overview, 442 thrombocytopenic syndromes, 1961 thrombotic microangiopathy, 1966-1967, 1997-1999 190, [193] [194] Extrinsic coagulation pathway, 1886f Extrinsic tenase, 1835-1836, 1899-1901, 1900f Ezetimibe, 2124-2125 EZH. See Enhancer of zeste homolog F F box and leucin-rich repeat protein 5 (FBXL5), 468, 470f F box and WD repeat domain containing 7 (FBXW7), 1016 F cells, 302-303 F4/80, 331-332 F8 gene, 2001, 2002f, 2003-2004, 2006 . See also Factor VIII F9 gene, 2004 , 2004f-2005f, 2006 2018 , 2025 -2027 , 2026f treatment of, 2028 -2031 , 2029b Factor VIIIa, 1902 Factor VIII:C level assay, 2059 Factor V Leiden gain-of-function mutation, 2079 -2080 Factor X, 1778 , 1907 -1909 , 2043 -2044 , 2102 Factor Xa, 1902 , 2065 -2066 Factor XI deficiency, 1778 -1779 , 2044 -2045 , 2211b Factor XII, 1891 , 2045 -2046 , 2046b , 2065 , 2102 Factor XIII deficiency, 1779 , 1929 , 2047 -2048 , 1906-1907 antiphospholipid syndrome and, 2099 clinical assessment and, 1914 coagulation and, 1834-1837, 1835f, 1906, 1909 connectivity and dynamics in, 1898-1904, 1900f-1901f, 1903f developmental, 2189-2191, 2190t disorders of, 1839-1841, 1839t-1840t, 2191 fibrinolysis and, 1837-1839, 1838f key events in, 1906, 1907f , 1831, 1886f, 1923f-1924f platelets and, 1832-1834, 1833f procoagulant extravascular space and, 1907-1909, 1908f regulators of, 1909, 1910f surgery and, 2304-2305 1974-1975, 1977t-1978t conceptual framework for, 1982f differential diagnosis for, 1974, 1974b, 2071-2072 epidemiology of, 1973, 1974t laboratory diagnosis of, 1975-1977, 1976f, 1981b in neonate, 2199-2200 overview of, 1973, 2081, 2176, 2176t pathobiology of, 1973, 1975f, 1982f platelet count monitoring for, 1981 prognosis for, 1977 therapy for, 1977-1981, 1980t, 1981b, 1982f , 1946 , -1947 , , 1947f epidemiology of, 1944 , HIV infection and, 2273 , -2275 , intravenous immunoglobulin for, 1753 , -1754 , overview of, 1944 , , 1946t pathophysiology of, 1944 , -1945 , , 1945t pregnancy and, 2205 , -2206 , , 2206t primary and secondary immune, 1945 , -1946 , refractory, 1950 , second-line therapy for, 1948 , -1950 , tolerance, immunity and, 285 treatment of, 340-341, 1947 , -1948 , , 1947f, 1950 1961-1965, 1962f, 1963b, 1963t 1922 physiology underlying, 1922, 1925f practical approach, 1926-1927 specific, 1925-1926 of fibrinolysis, 1929 global hemostasis assays, 1929 overview of, 1917-1918, 1917b-1918b, 1922 , 1997 -1998 Nephrotic syndrome, 1132 , 1752 , 2227 , 2244 -2245 Nepmucin, 1844 -1845 pediatric, 1488 , 1489t, 1490 -1492 psychosocial considerations, 1466 , 1491 -1492 , 1492t relief of suffering and, 1490 -1491 Palmitoylation, 60-61 Palonosetron, 1484 Pamidronate, 1415 Pancreas, 362-363, 362f, 531-532 Pancytopenia, 350-372, 395t, 405, 2218 , 2232 1991 Platelet-activating antibodies, 1943 Platelet-associated IgG (PAIgG), 1945 , 1958 , 1973 Platelet-derived growth factors (PDGF), 153, 1847f, 1848 , 2127 , 2127f Plateletpheresis, 1785 -1786 1831-1834, 1833f, 1839-1840, 1839t, 1906-1909, 1908f, 2190 Peripheral T-cell lymphomas (PTCL) (Continued)",
            "cite_spans": [
                {
                    "start": 56,
                    "end": 65,
                    "text": "for, 1984",
                    "ref_id": null
                },
                {
                    "start": 66,
                    "end": 111,
                    "text": "eculizumab and, 282-283 epidemiology of, 1993",
                    "ref_id": null
                },
                {
                    "start": 112,
                    "end": 146,
                    "text": "laboratory manifestations of, 1994",
                    "ref_id": null
                },
                {
                    "start": 147,
                    "end": 152,
                    "text": "-1996",
                    "ref_id": null
                },
                {
                    "start": 153,
                    "end": 178,
                    "text": ", 1996t overview of, 1984",
                    "ref_id": null
                },
                {
                    "start": 179,
                    "end": 200,
                    "text": "pathobiology of, 1993",
                    "ref_id": null
                },
                {
                    "start": 201,
                    "end": 206,
                    "text": "-1994",
                    "ref_id": null
                },
                {
                    "start": 207,
                    "end": 240,
                    "text": ", 1994f-1995f prognosis for, 1996",
                    "ref_id": null
                },
                {
                    "start": 241,
                    "end": 258,
                    "text": "therapy for, 1996",
                    "ref_id": null
                },
                {
                    "start": 287,
                    "end": 291,
                    "text": "1359",
                    "ref_id": null
                },
                {
                    "start": 292,
                    "end": 298,
                    "text": ", 1857",
                    "ref_id": null
                },
                {
                    "start": 377,
                    "end": 406,
                    "text": "purpura and, 1944-1945, 1945t",
                    "ref_id": null
                },
                {
                    "start": 481,
                    "end": 502,
                    "text": "and, 1945t, 1953-1954",
                    "ref_id": null
                },
                {
                    "start": 503,
                    "end": 550,
                    "text": ", 191-193 apoptosis and, 186-187, 190-191, 191f",
                    "ref_id": null
                },
                {
                    "start": 551,
                    "end": 647,
                    "text": "Basophils, 203, 331 Batroxobin, 1927 BAX, 190-193, 193f 4-1BB, T cell activation and, 226 B-cell",
                    "ref_id": null
                },
                {
                    "start": 726,
                    "end": 736,
                    "text": "CD22, 1050",
                    "ref_id": null
                },
                {
                    "start": 737,
                    "end": 750,
                    "text": ", 1052t, 1288",
                    "ref_id": null
                },
                {
                    "start": 751,
                    "end": 776,
                    "text": "CD25, 228, 718 CD26, 1647",
                    "ref_id": null
                },
                {
                    "start": 777,
                    "end": 792,
                    "text": "CD27, 226, 1421",
                    "ref_id": null
                },
                {
                    "start": 793,
                    "end": 798,
                    "text": "-1422",
                    "ref_id": null
                },
                {
                    "start": 799,
                    "end": 847,
                    "text": "CD28, 225-226, 226f, 288 CD3, 223-224 CD30, 1339",
                    "ref_id": null
                },
                {
                    "start": 848,
                    "end": 877,
                    "text": "CD33, 321, 938-939, 991, 1154",
                    "ref_id": null
                },
                {
                    "start": 878,
                    "end": 884,
                    "text": ", 1167",
                    "ref_id": null
                },
                {
                    "start": 885,
                    "end": 904,
                    "text": "CD34, 299-300, 1129",
                    "ref_id": null
                },
                {
                    "start": 905,
                    "end": 910,
                    "text": "-1131",
                    "ref_id": null
                },
                {
                    "start": 911,
                    "end": 917,
                    "text": ", 1135",
                    "ref_id": null
                },
                {
                    "start": 918,
                    "end": 973,
                    "text": "CD34+ hematopoietic stem cells anticoagulants and, 1526",
                    "ref_id": null
                },
                {
                    "start": 974,
                    "end": 993,
                    "text": "apheresis and, 1524",
                    "ref_id": null
                },
                {
                    "start": 994,
                    "end": 999,
                    "text": "-1526",
                    "ref_id": null
                },
                {
                    "start": 1000,
                    "end": 1007,
                    "text": ", 1525b",
                    "ref_id": null
                },
                {
                    "start": 1529,
                    "end": 1533,
                    "text": "1524",
                    "ref_id": null
                },
                {
                    "start": 1534,
                    "end": 1539,
                    "text": "-1525",
                    "ref_id": null
                },
                {
                    "start": 1540,
                    "end": 1587,
                    "text": "CD35, 269-272, 271f CD36, 130, 130f, 130t, 2130",
                    "ref_id": null
                },
                {
                    "start": 1588,
                    "end": 1598,
                    "text": "CD38, 1251",
                    "ref_id": null
                },
                {
                    "start": 1599,
                    "end": 1609,
                    "text": "CD39, 1831",
                    "ref_id": null
                },
                {
                    "start": 1610,
                    "end": 1615,
                    "text": "-1832",
                    "ref_id": null
                },
                {
                    "start": 1647,
                    "end": 1651,
                    "text": "1655",
                    "ref_id": null
                },
                {
                    "start": 1652,
                    "end": 1657,
                    "text": "-1656",
                    "ref_id": null
                },
                {
                    "start": 1658,
                    "end": 1682,
                    "text": "HIV life cycle and, 2263",
                    "ref_id": null
                },
                {
                    "start": 1683,
                    "end": 1688,
                    "text": "-2264",
                    "ref_id": null
                },
                {
                    "start": 1689,
                    "end": 1750,
                    "text": "T cell development and, 224f, 228-229, 231 CD4+ T cells, 1666",
                    "ref_id": null
                },
                {
                    "start": 1751,
                    "end": 1757,
                    "text": ", 1724",
                    "ref_id": null
                },
                {
                    "start": 1758,
                    "end": 1764,
                    "text": ", 2266",
                    "ref_id": null
                },
                {
                    "start": 1765,
                    "end": 1770,
                    "text": "-2267",
                    "ref_id": null
                },
                {
                    "start": 1771,
                    "end": 1851,
                    "text": "CD4+Th cells, 231 CD40, 288, 715 CD40 ligand (CD40LG) deficiency, 715 CD43, 1154",
                    "ref_id": null
                },
                {
                    "start": 1852,
                    "end": 1878,
                    "text": "CD44, 124, 130, 130t, 1154",
                    "ref_id": null
                },
                {
                    "start": 1879,
                    "end": 1900,
                    "text": "CD45, 172, 173t, 1154",
                    "ref_id": null
                },
                {
                    "start": 1901,
                    "end": 1907,
                    "text": ", 1268",
                    "ref_id": null
                },
                {
                    "start": 1908,
                    "end": 1928,
                    "text": "CD47, 125 CD48, 1575",
                    "ref_id": null
                },
                {
                    "start": 1980,
                    "end": 2039,
                    "text": "97-98 CD55, 417-418 CD56, 240, 241f, 241t, 1575 CD56 bright",
                    "ref_id": null
                },
                {
                    "start": 2040,
                    "end": 2051,
                    "text": "system and,",
                    "ref_id": null
                },
                {
                    "start": 2052,
                    "end": 2057,
                    "text": "[154]",
                    "ref_id": null
                },
                {
                    "start": 2058,
                    "end": 2063,
                    "text": "[155]",
                    "ref_id": null
                },
                {
                    "start": 2064,
                    "end": 2068,
                    "text": "523,",
                    "ref_id": null
                },
                {
                    "start": 2069,
                    "end": 2074,
                    "text": "[851]",
                    "ref_id": null
                },
                {
                    "start": 2075,
                    "end": 2080,
                    "text": "[852]",
                    "ref_id": null
                },
                {
                    "start": 2081,
                    "end": 2086,
                    "text": "[853]",
                    "ref_id": null
                },
                {
                    "start": 2087,
                    "end": 2103,
                    "text": "851f Cell death,",
                    "ref_id": null
                },
                {
                    "start": 2104,
                    "end": 2108,
                    "text": "186,",
                    "ref_id": null
                },
                {
                    "start": 2109,
                    "end": 2114,
                    "text": "[194]",
                    "ref_id": null
                },
                {
                    "start": 2115,
                    "end": 2120,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 2340,
                    "end": 2351,
                    "text": "1 and, 1583",
                    "ref_id": null
                },
                {
                    "start": 2352,
                    "end": 2364,
                    "text": "1 and, -1586",
                    "ref_id": null
                },
                {
                    "start": 2441,
                    "end": 2474,
                    "text": "335, 706, 706t, 719 Cheeses, 1458",
                    "ref_id": null
                },
                {
                    "start": 2475,
                    "end": 2572,
                    "text": "Chelation therapy, 489, 489b, 554-555, 592, 964 Chemistry, Manufacturing, and Control (CMC), 1534",
                    "ref_id": null
                },
                {
                    "start": 2573,
                    "end": 2579,
                    "text": ", 1542",
                    "ref_id": null
                },
                {
                    "start": 2580,
                    "end": 2604,
                    "text": "Chemoimmunotherapy, 1255",
                    "ref_id": null
                },
                {
                    "start": 2605,
                    "end": 2610,
                    "text": "-1256",
                    "ref_id": null
                },
                {
                    "start": 2611,
                    "end": 2617,
                    "text": ", 1294",
                    "ref_id": null
                },
                {
                    "start": 2618,
                    "end": 2622,
                    "text": "1384",
                    "ref_id": null
                },
                {
                    "start": 2623,
                    "end": 2759,
                    "text": "3, 796, 796f 5, 793-794, 944, 952, 960, 960f, 964-965. See also Del(5q) 6, 825 7, 794, 952 11, 805, 806f, 824-825 13, 822, 830-831, 1384",
                    "ref_id": null
                },
                {
                    "start": 2760,
                    "end": 2783,
                    "text": "17, 795, 825, 952, 1384",
                    "ref_id": null
                },
                {
                    "start": 2784,
                    "end": 2800,
                    "text": "20, 952 21, 1017",
                    "ref_id": null
                },
                {
                    "start": 2801,
                    "end": 2806,
                    "text": "-1018",
                    "ref_id": null
                },
                {
                    "start": 2807,
                    "end": 2813,
                    "text": ", 1156",
                    "ref_id": null
                },
                {
                    "start": 2814,
                    "end": 2819,
                    "text": "-1157",
                    "ref_id": null
                },
                {
                    "start": 2820,
                    "end": 2835,
                    "text": "Cidofovir, 1455",
                    "ref_id": null
                },
                {
                    "start": 2836,
                    "end": 2852,
                    "text": "Cilostazol, 1936",
                    "ref_id": null
                },
                {
                    "start": 2853,
                    "end": 2859,
                    "text": ", 2165",
                    "ref_id": null
                },
                {
                    "start": 2860,
                    "end": 2892,
                    "text": "CIP1. See P21 Circumcision, 2009",
                    "ref_id": null
                },
                {
                    "start": 2893,
                    "end": 2908,
                    "text": "Cirrhosis, 1752",
                    "ref_id": null
                },
                {
                    "start": 2909,
                    "end": 2991,
                    "text": "Cis-acting elements, defined, 9 Cisplatin, 860-861, 902 Cistrome, 20 Citrate, 1707",
                    "ref_id": null
                },
                {
                    "start": 2992,
                    "end": 2998,
                    "text": ", 1851",
                    "ref_id": null
                },
                {
                    "start": 2999,
                    "end": 3006,
                    "text": ", -1852",
                    "ref_id": null
                },
                {
                    "start": 3007,
                    "end": 3038,
                    "text": ", , 1851f factor VIII and, 2003",
                    "ref_id": null
                },
                {
                    "start": 3039,
                    "end": 3061,
                    "text": ", hemostasis and, 1834",
                    "ref_id": null
                },
                {
                    "start": 3062,
                    "end": 3069,
                    "text": ", -1837",
                    "ref_id": null
                },
                {
                    "start": 3070,
                    "end": 3099,
                    "text": ", , 1835f key events in, 1906",
                    "ref_id": null
                },
                {
                    "start": 3100,
                    "end": 3159,
                    "text": ", , 1907f, 2035f laboratory evaluation of methodology, 1922",
                    "ref_id": null
                },
                {
                    "start": 3160,
                    "end": 3189,
                    "text": ", physiology underlying, 1922",
                    "ref_id": null
                },
                {
                    "start": 3190,
                    "end": 3224,
                    "text": ", , 1925f practical approach, 1926",
                    "ref_id": null
                },
                {
                    "start": 3233,
                    "end": 3257,
                    "text": ", , 1927t specific, 1925",
                    "ref_id": null
                },
                {
                    "start": 3258,
                    "end": 3265,
                    "text": ", -1926",
                    "ref_id": null
                },
                {
                    "start": 3266,
                    "end": 3272,
                    "text": ", 1978",
                    "ref_id": null
                },
                {
                    "start": 3273,
                    "end": 3278,
                    "text": "-1979",
                    "ref_id": null
                },
                {
                    "start": 3279,
                    "end": 3336,
                    "text": ", 1979t-1980t Danazol, 429 Dapsone, 671 Daratumumab, 1415",
                    "ref_id": null
                },
                {
                    "start": 3337,
                    "end": 3343,
                    "text": ", 1979",
                    "ref_id": null
                },
                {
                    "start": 3344,
                    "end": 3349,
                    "text": "-1980",
                    "ref_id": null
                },
                {
                    "start": 3350,
                    "end": 3369,
                    "text": ", 1979t-1980t, 2178",
                    "ref_id": null
                },
                {
                    "start": 3370,
                    "end": 3375,
                    "text": "-2179",
                    "ref_id": null
                },
                {
                    "start": 3380,
                    "end": 3393,
                    "text": "(D-ITP), 1961",
                    "ref_id": null
                },
                {
                    "start": 3394,
                    "end": 3408,
                    "text": "(D-ITP), -1965",
                    "ref_id": null
                },
                {
                    "start": 3409,
                    "end": 3432,
                    "text": "(D-ITP), , 1962f, 1963b",
                    "ref_id": null
                },
                {
                    "start": 3551,
                    "end": 3601,
                    "text": "670-671, 671b platelet disorders, 1932-1939, 1933t",
                    "ref_id": null
                },
                {
                    "start": 3777,
                    "end": 3985,
                    "text": "1961-1965, 1963b, 1963t immune of rapid onset, 1965-1966 mechanisms of, 1962f miscellaneous syndromes, 1966-1967 overview, 442 thrombocytopenic syndromes, 1961 thrombotic microangiopathy, 1966-1967, 1997-1999",
                    "ref_id": null
                },
                {
                    "start": 3986,
                    "end": 3990,
                    "text": "190,",
                    "ref_id": null
                },
                {
                    "start": 3991,
                    "end": 3996,
                    "text": "[193]",
                    "ref_id": null
                },
                {
                    "start": 3997,
                    "end": 4002,
                    "text": "[194]",
                    "ref_id": null
                },
                {
                    "start": 4058,
                    "end": 4085,
                    "text": "1835-1836, 1899-1901, 1900f",
                    "ref_id": null
                },
                {
                    "start": 4265,
                    "end": 4325,
                    "text": "302-303 F4/80, 331-332 F8 gene, 2001, 2002f, 2003-2004, 2006",
                    "ref_id": null
                },
                {
                    "start": 4337,
                    "end": 4362,
                    "text": "Factor VIII F9 gene, 2004",
                    "ref_id": null
                },
                {
                    "start": 4363,
                    "end": 4382,
                    "text": ", 2004f-2005f, 2006",
                    "ref_id": null
                },
                {
                    "start": 4383,
                    "end": 4387,
                    "text": "2018",
                    "ref_id": null
                },
                {
                    "start": 4388,
                    "end": 4394,
                    "text": ", 2025",
                    "ref_id": null
                },
                {
                    "start": 4395,
                    "end": 4400,
                    "text": "-2027",
                    "ref_id": null
                },
                {
                    "start": 4401,
                    "end": 4427,
                    "text": ", 2026f treatment of, 2028",
                    "ref_id": null
                },
                {
                    "start": 4428,
                    "end": 4433,
                    "text": "-2031",
                    "ref_id": null
                },
                {
                    "start": 4434,
                    "end": 4441,
                    "text": ", 2029b",
                    "ref_id": null
                },
                {
                    "start": 4442,
                    "end": 4460,
                    "text": "Factor VIIIa, 1902",
                    "ref_id": null
                },
                {
                    "start": 4536,
                    "end": 4540,
                    "text": "2079",
                    "ref_id": null
                },
                {
                    "start": 4541,
                    "end": 4546,
                    "text": "-2080",
                    "ref_id": null
                },
                {
                    "start": 4547,
                    "end": 4561,
                    "text": "Factor X, 1778",
                    "ref_id": null
                },
                {
                    "start": 4562,
                    "end": 4568,
                    "text": ", 1907",
                    "ref_id": null
                },
                {
                    "start": 4575,
                    "end": 4581,
                    "text": ", 2043",
                    "ref_id": null
                },
                {
                    "start": 4582,
                    "end": 4587,
                    "text": "-2044",
                    "ref_id": null
                },
                {
                    "start": 4588,
                    "end": 4594,
                    "text": ", 2102",
                    "ref_id": null
                },
                {
                    "start": 4595,
                    "end": 4610,
                    "text": "Factor Xa, 1902",
                    "ref_id": null
                },
                {
                    "start": 4611,
                    "end": 4617,
                    "text": ", 2065",
                    "ref_id": null
                },
                {
                    "start": 4618,
                    "end": 4623,
                    "text": "-2066",
                    "ref_id": null
                },
                {
                    "start": 4624,
                    "end": 4650,
                    "text": "Factor XI deficiency, 1778",
                    "ref_id": null
                },
                {
                    "start": 4651,
                    "end": 4656,
                    "text": "-1779",
                    "ref_id": null
                },
                {
                    "start": 4657,
                    "end": 4663,
                    "text": ", 2044",
                    "ref_id": null
                },
                {
                    "start": 4664,
                    "end": 4669,
                    "text": "-2045",
                    "ref_id": null
                },
                {
                    "start": 4670,
                    "end": 4677,
                    "text": ", 2211b",
                    "ref_id": null
                },
                {
                    "start": 4678,
                    "end": 4694,
                    "text": "Factor XII, 1891",
                    "ref_id": null
                },
                {
                    "start": 4695,
                    "end": 4701,
                    "text": ", 2045",
                    "ref_id": null
                },
                {
                    "start": 4702,
                    "end": 4707,
                    "text": "-2046",
                    "ref_id": null
                },
                {
                    "start": 4708,
                    "end": 4715,
                    "text": ", 2046b",
                    "ref_id": null
                },
                {
                    "start": 4716,
                    "end": 4722,
                    "text": ", 2065",
                    "ref_id": null
                },
                {
                    "start": 4723,
                    "end": 4729,
                    "text": ", 2102",
                    "ref_id": null
                },
                {
                    "start": 4730,
                    "end": 4758,
                    "text": "Factor XIII deficiency, 1779",
                    "ref_id": null
                },
                {
                    "start": 4759,
                    "end": 4765,
                    "text": ", 1929",
                    "ref_id": null
                },
                {
                    "start": 4766,
                    "end": 4772,
                    "text": ", 2047",
                    "ref_id": null
                },
                {
                    "start": 4773,
                    "end": 4778,
                    "text": "-2048",
                    "ref_id": null
                },
                {
                    "start": 4779,
                    "end": 5099,
                    "text": ", 1906-1907 antiphospholipid syndrome and, 2099 clinical assessment and, 1914 coagulation and, 1834-1837, 1835f, 1906, 1909 connectivity and dynamics in, 1898-1904, 1900f-1901f, 1903f developmental, 2189-2191, 2190t disorders of, 1839-1841, 1839t-1840t, 2191 fibrinolysis and, 1837-1839, 1838f key events in, 1906, 1907f",
                    "ref_id": null
                },
                {
                    "start": 5100,
                    "end": 5263,
                    "text": ", 1831, 1886f, 1923f-1924f platelets and, 1832-1834, 1833f procoagulant extravascular space and, 1907-1909, 1908f regulators of, 1909, 1910f surgery and, 2304-2305",
                    "ref_id": null
                },
                {
                    "start": 5264,
                    "end": 5286,
                    "text": "1974-1975, 1977t-1978t",
                    "ref_id": null
                },
                {
                    "start": 5347,
                    "end": 5642,
                    "text": "1974, 1974b, 2071-2072 epidemiology of, 1973, 1974t laboratory diagnosis of, 1975-1977, 1976f, 1981b in neonate, 2199-2200 overview of, 1973, 2081, 2176, 2176t pathobiology of, 1973, 1975f, 1982f platelet count monitoring for, 1981 prognosis for, 1977 therapy for, 1977-1981, 1980t, 1981b, 1982f",
                    "ref_id": null
                },
                {
                    "start": 5643,
                    "end": 5649,
                    "text": ", 1946",
                    "ref_id": null
                },
                {
                    "start": 5650,
                    "end": 5657,
                    "text": ", -1947",
                    "ref_id": null
                },
                {
                    "start": 5658,
                    "end": 5689,
                    "text": ", , 1947f epidemiology of, 1944",
                    "ref_id": null
                },
                {
                    "start": 5690,
                    "end": 5715,
                    "text": ", HIV infection and, 2273",
                    "ref_id": null
                },
                {
                    "start": 5716,
                    "end": 5723,
                    "text": ", -2275",
                    "ref_id": null
                },
                {
                    "start": 5724,
                    "end": 5762,
                    "text": ", intravenous immunoglobulin for, 1753",
                    "ref_id": null
                },
                {
                    "start": 5763,
                    "end": 5770,
                    "text": ", -1754",
                    "ref_id": null
                },
                {
                    "start": 5771,
                    "end": 5790,
                    "text": ", overview of, 1944",
                    "ref_id": null
                },
                {
                    "start": 5791,
                    "end": 5825,
                    "text": ", , 1946t pathophysiology of, 1944",
                    "ref_id": null
                },
                {
                    "start": 5826,
                    "end": 5833,
                    "text": ", -1945",
                    "ref_id": null
                },
                {
                    "start": 5834,
                    "end": 5863,
                    "text": ", , 1945t pregnancy and, 2205",
                    "ref_id": null
                },
                {
                    "start": 5864,
                    "end": 5871,
                    "text": ", -2206",
                    "ref_id": null
                },
                {
                    "start": 5872,
                    "end": 5916,
                    "text": ", , 2206t primary and secondary immune, 1945",
                    "ref_id": null
                },
                {
                    "start": 5917,
                    "end": 5924,
                    "text": ", -1946",
                    "ref_id": null
                },
                {
                    "start": 5925,
                    "end": 5943,
                    "text": ", refractory, 1950",
                    "ref_id": null
                },
                {
                    "start": 5944,
                    "end": 5975,
                    "text": ", second-line therapy for, 1948",
                    "ref_id": null
                },
                {
                    "start": 5976,
                    "end": 5983,
                    "text": ", -1950",
                    "ref_id": null
                },
                {
                    "start": 5984,
                    "end": 6042,
                    "text": ", tolerance, immunity and, 285 treatment of, 340-341, 1947",
                    "ref_id": null
                },
                {
                    "start": 6043,
                    "end": 6050,
                    "text": ", -1948",
                    "ref_id": null
                },
                {
                    "start": 6051,
                    "end": 6066,
                    "text": ", , 1947f, 1950",
                    "ref_id": null
                },
                {
                    "start": 6067,
                    "end": 6097,
                    "text": "1961-1965, 1962f, 1963b, 1963t",
                    "ref_id": null
                },
                {
                    "start": 6098,
                    "end": 6282,
                    "text": "1922 physiology underlying, 1922, 1925f practical approach, 1926-1927 specific, 1925-1926 of fibrinolysis, 1929 global hemostasis assays, 1929 overview of, 1917-1918, 1917b-1918b, 1922",
                    "ref_id": null
                },
                {
                    "start": 6290,
                    "end": 6295,
                    "text": "-1998",
                    "ref_id": null
                },
                {
                    "start": 6296,
                    "end": 6320,
                    "text": "Nephrotic syndrome, 1132",
                    "ref_id": null
                },
                {
                    "start": 6321,
                    "end": 6327,
                    "text": ", 1752",
                    "ref_id": null
                },
                {
                    "start": 6328,
                    "end": 6334,
                    "text": ", 2227",
                    "ref_id": null
                },
                {
                    "start": 6335,
                    "end": 6341,
                    "text": ", 2244",
                    "ref_id": null
                },
                {
                    "start": 6342,
                    "end": 6347,
                    "text": "-2245",
                    "ref_id": null
                },
                {
                    "start": 6348,
                    "end": 6362,
                    "text": "Nepmucin, 1844",
                    "ref_id": null
                },
                {
                    "start": 6363,
                    "end": 6368,
                    "text": "-1845",
                    "ref_id": null
                },
                {
                    "start": 6369,
                    "end": 6384,
                    "text": "pediatric, 1488",
                    "ref_id": null
                },
                {
                    "start": 6385,
                    "end": 6398,
                    "text": ", 1489t, 1490",
                    "ref_id": null
                },
                {
                    "start": 6399,
                    "end": 6404,
                    "text": "-1492",
                    "ref_id": null
                },
                {
                    "start": 6405,
                    "end": 6438,
                    "text": "psychosocial considerations, 1466",
                    "ref_id": null
                },
                {
                    "start": 6439,
                    "end": 6445,
                    "text": ", 1491",
                    "ref_id": null
                },
                {
                    "start": 6446,
                    "end": 6451,
                    "text": "-1492",
                    "ref_id": null
                },
                {
                    "start": 6452,
                    "end": 6489,
                    "text": ", 1492t relief of suffering and, 1490",
                    "ref_id": null
                },
                {
                    "start": 6490,
                    "end": 6495,
                    "text": "-1491",
                    "ref_id": null
                },
                {
                    "start": 6496,
                    "end": 6536,
                    "text": "Palmitoylation, 60-61 Palonosetron, 1484",
                    "ref_id": null
                },
                {
                    "start": 6537,
                    "end": 6554,
                    "text": "Pamidronate, 1415",
                    "ref_id": null
                },
                {
                    "start": 6555,
                    "end": 6626,
                    "text": "Pancreas, 362-363, 362f, 531-532 Pancytopenia, 350-372, 395t, 405, 2218",
                    "ref_id": null
                },
                {
                    "start": 6627,
                    "end": 6633,
                    "text": ", 2232",
                    "ref_id": null
                },
                {
                    "start": 6634,
                    "end": 6638,
                    "text": "1991",
                    "ref_id": null
                },
                {
                    "start": 6639,
                    "end": 6675,
                    "text": "Platelet-activating antibodies, 1943",
                    "ref_id": null
                },
                {
                    "start": 6676,
                    "end": 6713,
                    "text": "Platelet-associated IgG (PAIgG), 1945",
                    "ref_id": null
                },
                {
                    "start": 6714,
                    "end": 6720,
                    "text": ", 1958",
                    "ref_id": null
                },
                {
                    "start": 6721,
                    "end": 6727,
                    "text": ", 1973",
                    "ref_id": null
                },
                {
                    "start": 6728,
                    "end": 6784,
                    "text": "Platelet-derived growth factors (PDGF), 153, 1847f, 1848",
                    "ref_id": null
                },
                {
                    "start": 6785,
                    "end": 6791,
                    "text": ", 2127",
                    "ref_id": null
                },
                {
                    "start": 6792,
                    "end": 6822,
                    "text": ", 2127f Plateletpheresis, 1785",
                    "ref_id": null
                },
                {
                    "start": 6823,
                    "end": 6828,
                    "text": "-1786",
                    "ref_id": null
                },
                {
                    "start": 6829,
                    "end": 6887,
                    "text": "1831-1834, 1833f, 1839-1840, 1839t, 1906-1909, 1908f, 2190",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "interactions of with vessel wall, 1854-1855 liver disease and, 2238-2239 molecular basis of function of activation, 1873 -1878 adhesion, 1870 -1873 aggregation, 1878 -1880 inherited disorders, 1880 -1884 overview, 1870 overview of, 1857 pediatric, 1821 physiologic sequestration of, 1959 -1960 , 1959f polycythemia vera and, 1099 -1101 segregation of, 1896f structure of, 1865 -1868 , 1865f-1866f thrombopoietin and, 340, 340f von Willebrand factor and, 2051 1952-1953, 1953b diagnosis of, 1953 epidemiology of, 1952-1953, 1953f 429 Preeclampsia, 1967 , 2069 , 2206 -2207 Pregabalin, 1480 Pregnancy anemias in, 2203 -2205 antiphospholipid syndrome and, 2096 , 2099 -2100 , 2213 , 2213t aplastic anemia and, 402-403 autoimmune hemolytic anemia in, 653 bleeding disorders and, 2210 Chagas disease and, 2297 clinical assessment and, 1916 , 1916b disseminated intravascular coagulation and, 2069 folate and, 533-534 hemoglobinopathies and, 2204 hemophilias and, 2210 -2211 Hodgkin lymphoma and, 1227 late complications and, 1500 leukemias, lymphomas and, 2208 -2210 malaria and, 2284 prophylactic anticoagulation during, 2212 pure red cell aplasia and, 426-427 sickle cell disease and, 601 thrombocytopenia and, 1946 , 1957t, 1967 thrombophilia and, 2212 -2213 , 2213b thrombotic microangiopathies and, 1999 venous thromboembolism and, 2082 -2083 , 2086 , 2109 -2111 , 2211 -2212 warfarin therapy and, 2181 Prekallikrein, 1891 , 2046 -2047 antibodies and, 2090 antibodies and, deficiency in, 2078 antibodies and, -2079 antibodies and, , 2078f, 2078t disseminated intravascular coagulation and, 2066 antibodies and, -2067 antibodies and, , 2066f endothelial cells and, 1852 antibodies and, hemostasis and, 1909 antibodies and, HIV infection and, 2275 antibodies and, -2276 antibodies and, overview of, 2078 , 47-48 Proteome, 45 Prothrombin, 2080 , 2094 -2095 Prothrombin complex concentrates (PCC), 1765 , 1774 , 2029 , 2040 -2041 , 2241 Prothrombin deficiency, 1778 , 1840 , 2040 -2041 in neonates, 2189 , 2195 overview of, 1924 -1927 , 1927t, e12b prolonged, 2195 surgical patients and, 2304 -2305 Prothrombinase, 1837 , 1907 -1909 Prothrombitic states, evaluation of, 1929 -1930 , 664, 1962 , 664, , 1966 , 664, -1967 , 664, , 1998 , 1345 -1346 , 1348 , 2328 -2329 anatomy and physiology of, 1958 -1960 approach to patient with, 1955 -1958 , 1958t cancer and, 2248 cardiovascular disease and, 1971 chemotherapy, irradiation and, 442 in children, 2217 , 2231 cyclic, 443 diagnosing, 443b differential diagnosis for, 1957f, 1957t, 1960t, 1984 , 2071 , 2072t drug-induced autoimmune thrombocytopenia, 1965 immune of rapid onset, 1965 -1966 immune thrombocytopenia, 1961 -1965 , 1962f, 1963b , 1963t miscellaneous syndromes, 1966 -1967 overview, 442 thrombocytopenic syndromes, 1961 ethanol and, 442 GATA1 and, 344 glycoprotein IIB/IIIA receptor antagonists and, 1966 gold-induced, 1965 heparin-induced. See Heparin-induced thrombocytopenia HIV infection and, 2266b , 2273 -2275 hypersplenism and, 1960 -1961 idiopathic. , 1955, 1956t-1957t pregnancy and, 1967-1971, 2205- 2019-2020, 2019t hemostasis and, 1832, 1832f, 1837, 1909, 1910f laboratory evaluation of, e13b thromboembolism and, 2102 Tissue factor (TF) angiogenesis and, 1849 atherothrombosis and, 2129 cancer, thrombosis, and, 2250-2251 coagulation and, 1889, 1890f, 1903f disseminated intravascular coagulation and, 2064-2066 hemostasis and, 1907-1909, 1908f factor VIII and, 2002 -2003 factor VIII inhibitors and, 2025 -2027 functions of, 2051 , 2052f genetics of, 2051 -2052 , 2053f hemostasis and, 1832 -1834 , 1839 -1840 , 1839t, 1907 -1909 , 1910f in neonate, 2189 platelet adhesion and, 132-133, 1872 storage and secretion of, 2054 von Willebrand syndrome (VWS), 1093 Vorapaxar, 2164 , 2173 Vorinostat, 875-876, 967, 1357 -1359 Vumon. See Teniposide",
            "cite_spans": [
                {
                    "start": 116,
                    "end": 120,
                    "text": "1873",
                    "ref_id": null
                },
                {
                    "start": 121,
                    "end": 126,
                    "text": "-1878",
                    "ref_id": null
                },
                {
                    "start": 127,
                    "end": 141,
                    "text": "adhesion, 1870",
                    "ref_id": null
                },
                {
                    "start": 142,
                    "end": 147,
                    "text": "-1873",
                    "ref_id": null
                },
                {
                    "start": 148,
                    "end": 165,
                    "text": "aggregation, 1878",
                    "ref_id": null
                },
                {
                    "start": 166,
                    "end": 171,
                    "text": "-1880",
                    "ref_id": null
                },
                {
                    "start": 172,
                    "end": 197,
                    "text": "inherited disorders, 1880",
                    "ref_id": null
                },
                {
                    "start": 198,
                    "end": 203,
                    "text": "-1884",
                    "ref_id": null
                },
                {
                    "start": 204,
                    "end": 218,
                    "text": "overview, 1870",
                    "ref_id": null
                },
                {
                    "start": 219,
                    "end": 236,
                    "text": "overview of, 1857",
                    "ref_id": null
                },
                {
                    "start": 237,
                    "end": 252,
                    "text": "pediatric, 1821",
                    "ref_id": null
                },
                {
                    "start": 253,
                    "end": 287,
                    "text": "physiologic sequestration of, 1959",
                    "ref_id": null
                },
                {
                    "start": 288,
                    "end": 293,
                    "text": "-1960",
                    "ref_id": null
                },
                {
                    "start": 294,
                    "end": 329,
                    "text": ", 1959f polycythemia vera and, 1099",
                    "ref_id": null
                },
                {
                    "start": 330,
                    "end": 335,
                    "text": "-1101",
                    "ref_id": null
                },
                {
                    "start": 336,
                    "end": 376,
                    "text": "segregation of, 1896f structure of, 1865",
                    "ref_id": null
                },
                {
                    "start": 377,
                    "end": 382,
                    "text": "-1868",
                    "ref_id": null
                },
                {
                    "start": 383,
                    "end": 458,
                    "text": ", 1865f-1866f thrombopoietin and, 340, 340f von Willebrand factor and, 2051",
                    "ref_id": null
                },
                {
                    "start": 459,
                    "end": 528,
                    "text": "1952-1953, 1953b diagnosis of, 1953 epidemiology of, 1952-1953, 1953f",
                    "ref_id": null
                },
                {
                    "start": 529,
                    "end": 551,
                    "text": "429 Preeclampsia, 1967",
                    "ref_id": null
                },
                {
                    "start": 552,
                    "end": 558,
                    "text": ", 2069",
                    "ref_id": null
                },
                {
                    "start": 559,
                    "end": 565,
                    "text": ", 2206",
                    "ref_id": null
                },
                {
                    "start": 566,
                    "end": 571,
                    "text": "-2207",
                    "ref_id": null
                },
                {
                    "start": 572,
                    "end": 588,
                    "text": "Pregabalin, 1480",
                    "ref_id": null
                },
                {
                    "start": 589,
                    "end": 615,
                    "text": "Pregnancy anemias in, 2203",
                    "ref_id": null
                },
                {
                    "start": 616,
                    "end": 621,
                    "text": "-2205",
                    "ref_id": null
                },
                {
                    "start": 622,
                    "end": 657,
                    "text": "antiphospholipid syndrome and, 2096",
                    "ref_id": null
                },
                {
                    "start": 658,
                    "end": 664,
                    "text": ", 2099",
                    "ref_id": null
                },
                {
                    "start": 665,
                    "end": 670,
                    "text": "-2100",
                    "ref_id": null
                },
                {
                    "start": 671,
                    "end": 677,
                    "text": ", 2213",
                    "ref_id": null
                },
                {
                    "start": 678,
                    "end": 779,
                    "text": ", 2213t aplastic anemia and, 402-403 autoimmune hemolytic anemia in, 653 bleeding disorders and, 2210",
                    "ref_id": null
                },
                {
                    "start": 780,
                    "end": 804,
                    "text": "Chagas disease and, 2297",
                    "ref_id": null
                },
                {
                    "start": 805,
                    "end": 834,
                    "text": "clinical assessment and, 1916",
                    "ref_id": null
                },
                {
                    "start": 835,
                    "end": 842,
                    "text": ", 1916b",
                    "ref_id": null
                },
                {
                    "start": 843,
                    "end": 891,
                    "text": "disseminated intravascular coagulation and, 2069",
                    "ref_id": null
                },
                {
                    "start": 892,
                    "end": 940,
                    "text": "folate and, 533-534 hemoglobinopathies and, 2204",
                    "ref_id": null
                },
                {
                    "start": 941,
                    "end": 962,
                    "text": "hemophilias and, 2210",
                    "ref_id": null
                },
                {
                    "start": 963,
                    "end": 968,
                    "text": "-2211",
                    "ref_id": null
                },
                {
                    "start": 969,
                    "end": 995,
                    "text": "Hodgkin lymphoma and, 1227",
                    "ref_id": null
                },
                {
                    "start": 996,
                    "end": 1024,
                    "text": "late complications and, 1500",
                    "ref_id": null
                },
                {
                    "start": 1025,
                    "end": 1055,
                    "text": "leukemias, lymphomas and, 2208",
                    "ref_id": null
                },
                {
                    "start": 1056,
                    "end": 1061,
                    "text": "-2210",
                    "ref_id": null
                },
                {
                    "start": 1062,
                    "end": 1079,
                    "text": "malaria and, 2284",
                    "ref_id": null
                },
                {
                    "start": 1080,
                    "end": 1121,
                    "text": "prophylactic anticoagulation during, 2212",
                    "ref_id": null
                },
                {
                    "start": 1122,
                    "end": 1212,
                    "text": "pure red cell aplasia and, 426-427 sickle cell disease and, 601 thrombocytopenia and, 1946",
                    "ref_id": null
                },
                {
                    "start": 1213,
                    "end": 1226,
                    "text": ", 1957t, 1967",
                    "ref_id": null
                },
                {
                    "start": 1227,
                    "end": 1250,
                    "text": "thrombophilia and, 2212",
                    "ref_id": null
                },
                {
                    "start": 1251,
                    "end": 1256,
                    "text": "-2213",
                    "ref_id": null
                },
                {
                    "start": 1257,
                    "end": 1264,
                    "text": ", 2213b",
                    "ref_id": null
                },
                {
                    "start": 1265,
                    "end": 1303,
                    "text": "thrombotic microangiopathies and, 1999",
                    "ref_id": null
                },
                {
                    "start": 1304,
                    "end": 1336,
                    "text": "venous thromboembolism and, 2082",
                    "ref_id": null
                },
                {
                    "start": 1337,
                    "end": 1342,
                    "text": "-2083",
                    "ref_id": null
                },
                {
                    "start": 1343,
                    "end": 1349,
                    "text": ", 2086",
                    "ref_id": null
                },
                {
                    "start": 1350,
                    "end": 1356,
                    "text": ", 2109",
                    "ref_id": null
                },
                {
                    "start": 1357,
                    "end": 1362,
                    "text": "-2111",
                    "ref_id": null
                },
                {
                    "start": 1363,
                    "end": 1369,
                    "text": ", 2211",
                    "ref_id": null
                },
                {
                    "start": 1370,
                    "end": 1375,
                    "text": "-2212",
                    "ref_id": null
                },
                {
                    "start": 1376,
                    "end": 1402,
                    "text": "warfarin therapy and, 2181",
                    "ref_id": null
                },
                {
                    "start": 1403,
                    "end": 1422,
                    "text": "Prekallikrein, 1891",
                    "ref_id": null
                },
                {
                    "start": 1423,
                    "end": 1429,
                    "text": ", 2046",
                    "ref_id": null
                },
                {
                    "start": 1430,
                    "end": 1435,
                    "text": "-2047",
                    "ref_id": null
                },
                {
                    "start": 1436,
                    "end": 1456,
                    "text": "antibodies and, 2090",
                    "ref_id": null
                },
                {
                    "start": 1457,
                    "end": 1492,
                    "text": "antibodies and, deficiency in, 2078",
                    "ref_id": null
                },
                {
                    "start": 1493,
                    "end": 1514,
                    "text": "antibodies and, -2079",
                    "ref_id": null
                },
                {
                    "start": 1515,
                    "end": 1594,
                    "text": "antibodies and, , 2078f, 2078t disseminated intravascular coagulation and, 2066",
                    "ref_id": null
                },
                {
                    "start": 1595,
                    "end": 1616,
                    "text": "antibodies and, -2067",
                    "ref_id": null
                },
                {
                    "start": 1617,
                    "end": 1668,
                    "text": "antibodies and, , 2066f endothelial cells and, 1852",
                    "ref_id": null
                },
                {
                    "start": 1669,
                    "end": 1705,
                    "text": "antibodies and, hemostasis and, 1909",
                    "ref_id": null
                },
                {
                    "start": 1706,
                    "end": 1745,
                    "text": "antibodies and, HIV infection and, 2275",
                    "ref_id": null
                },
                {
                    "start": 1746,
                    "end": 1767,
                    "text": "antibodies and, -2276",
                    "ref_id": null
                },
                {
                    "start": 1768,
                    "end": 1801,
                    "text": "antibodies and, overview of, 2078",
                    "ref_id": null
                },
                {
                    "start": 1802,
                    "end": 1840,
                    "text": ", 47-48 Proteome, 45 Prothrombin, 2080",
                    "ref_id": null
                },
                {
                    "start": 1841,
                    "end": 1847,
                    "text": ", 2094",
                    "ref_id": null
                },
                {
                    "start": 1848,
                    "end": 1853,
                    "text": "-2095",
                    "ref_id": null
                },
                {
                    "start": 1854,
                    "end": 1898,
                    "text": "Prothrombin complex concentrates (PCC), 1765",
                    "ref_id": null
                },
                {
                    "start": 1899,
                    "end": 1905,
                    "text": ", 1774",
                    "ref_id": null
                },
                {
                    "start": 1906,
                    "end": 1912,
                    "text": ", 2029",
                    "ref_id": null
                },
                {
                    "start": 1913,
                    "end": 1919,
                    "text": ", 2040",
                    "ref_id": null
                },
                {
                    "start": 1920,
                    "end": 1925,
                    "text": "-2041",
                    "ref_id": null
                },
                {
                    "start": 1926,
                    "end": 1932,
                    "text": ", 2241",
                    "ref_id": null
                },
                {
                    "start": 1933,
                    "end": 1961,
                    "text": "Prothrombin deficiency, 1778",
                    "ref_id": null
                },
                {
                    "start": 1962,
                    "end": 1968,
                    "text": ", 1840",
                    "ref_id": null
                },
                {
                    "start": 1969,
                    "end": 1975,
                    "text": ", 2040",
                    "ref_id": null
                },
                {
                    "start": 1976,
                    "end": 1981,
                    "text": "-2041",
                    "ref_id": null
                },
                {
                    "start": 1995,
                    "end": 1999,
                    "text": "2189",
                    "ref_id": null
                },
                {
                    "start": 2000,
                    "end": 2006,
                    "text": ", 2195",
                    "ref_id": null
                },
                {
                    "start": 2007,
                    "end": 2024,
                    "text": "overview of, 1924",
                    "ref_id": null
                },
                {
                    "start": 2031,
                    "end": 2060,
                    "text": ", 1927t, e12b prolonged, 2195",
                    "ref_id": null
                },
                {
                    "start": 2061,
                    "end": 2088,
                    "text": "surgical patients and, 2304",
                    "ref_id": null
                },
                {
                    "start": 2089,
                    "end": 2094,
                    "text": "-2305",
                    "ref_id": null
                },
                {
                    "start": 2095,
                    "end": 2115,
                    "text": "Prothrombinase, 1837",
                    "ref_id": null
                },
                {
                    "start": 2116,
                    "end": 2122,
                    "text": ", 1907",
                    "ref_id": null
                },
                {
                    "start": 2129,
                    "end": 2170,
                    "text": "Prothrombitic states, evaluation of, 1929",
                    "ref_id": null
                },
                {
                    "start": 2171,
                    "end": 2176,
                    "text": "-1930",
                    "ref_id": null
                },
                {
                    "start": 2177,
                    "end": 2188,
                    "text": ", 664, 1962",
                    "ref_id": null
                },
                {
                    "start": 2189,
                    "end": 2202,
                    "text": ", 664, , 1966",
                    "ref_id": null
                },
                {
                    "start": 2203,
                    "end": 2215,
                    "text": ", 664, -1967",
                    "ref_id": null
                },
                {
                    "start": 2216,
                    "end": 2229,
                    "text": ", 664, , 1998",
                    "ref_id": null
                },
                {
                    "start": 2230,
                    "end": 2236,
                    "text": ", 1345",
                    "ref_id": null
                },
                {
                    "start": 2237,
                    "end": 2242,
                    "text": "-1346",
                    "ref_id": null
                },
                {
                    "start": 2243,
                    "end": 2249,
                    "text": ", 1348",
                    "ref_id": null
                },
                {
                    "start": 2250,
                    "end": 2256,
                    "text": ", 2328",
                    "ref_id": null
                },
                {
                    "start": 2257,
                    "end": 2262,
                    "text": "-2329",
                    "ref_id": null
                },
                {
                    "start": 2263,
                    "end": 2294,
                    "text": "anatomy and physiology of, 1958",
                    "ref_id": null
                },
                {
                    "start": 2295,
                    "end": 2300,
                    "text": "-1960",
                    "ref_id": null
                },
                {
                    "start": 2301,
                    "end": 2331,
                    "text": "approach to patient with, 1955",
                    "ref_id": null
                },
                {
                    "start": 2332,
                    "end": 2337,
                    "text": "-1958",
                    "ref_id": null
                },
                {
                    "start": 2338,
                    "end": 2362,
                    "text": ", 1958t cancer and, 2248",
                    "ref_id": null
                },
                {
                    "start": 2363,
                    "end": 2395,
                    "text": "cardiovascular disease and, 1971",
                    "ref_id": null
                },
                {
                    "start": 2396,
                    "end": 2448,
                    "text": "chemotherapy, irradiation and, 442 in children, 2217",
                    "ref_id": null
                },
                {
                    "start": 2449,
                    "end": 2455,
                    "text": ", 2231",
                    "ref_id": null
                },
                {
                    "start": 2456,
                    "end": 2538,
                    "text": "cyclic, 443 diagnosing, 443b differential diagnosis for, 1957f, 1957t, 1960t, 1984",
                    "ref_id": null
                },
                {
                    "start": 2539,
                    "end": 2545,
                    "text": ", 2071",
                    "ref_id": null
                },
                {
                    "start": 2546,
                    "end": 2600,
                    "text": ", 2072t drug-induced autoimmune thrombocytopenia, 1965",
                    "ref_id": null
                },
                {
                    "start": 2601,
                    "end": 2628,
                    "text": "immune of rapid onset, 1965",
                    "ref_id": null
                },
                {
                    "start": 2629,
                    "end": 2634,
                    "text": "-1966",
                    "ref_id": null
                },
                {
                    "start": 2635,
                    "end": 2664,
                    "text": "immune thrombocytopenia, 1961",
                    "ref_id": null
                },
                {
                    "start": 2665,
                    "end": 2670,
                    "text": "-1965",
                    "ref_id": null
                },
                {
                    "start": 2671,
                    "end": 2685,
                    "text": ", 1962f, 1963b",
                    "ref_id": null
                },
                {
                    "start": 2686,
                    "end": 2723,
                    "text": ", 1963t miscellaneous syndromes, 1966",
                    "ref_id": null
                },
                {
                    "start": 2724,
                    "end": 2729,
                    "text": "-1967",
                    "ref_id": null
                },
                {
                    "start": 2730,
                    "end": 2776,
                    "text": "overview, 442 thrombocytopenic syndromes, 1961",
                    "ref_id": null
                },
                {
                    "start": 2777,
                    "end": 2861,
                    "text": "ethanol and, 442 GATA1 and, 344 glycoprotein IIB/IIIA receptor antagonists and, 1966",
                    "ref_id": null
                },
                {
                    "start": 2862,
                    "end": 2880,
                    "text": "gold-induced, 1965",
                    "ref_id": null
                },
                {
                    "start": 2881,
                    "end": 2959,
                    "text": "heparin-induced. See Heparin-induced thrombocytopenia HIV infection and, 2266b",
                    "ref_id": null
                },
                {
                    "start": 2960,
                    "end": 2966,
                    "text": ", 2273",
                    "ref_id": null
                },
                {
                    "start": 2967,
                    "end": 2972,
                    "text": "-2275",
                    "ref_id": null
                },
                {
                    "start": 2973,
                    "end": 2996,
                    "text": "hypersplenism and, 1960",
                    "ref_id": null
                },
                {
                    "start": 2997,
                    "end": 3002,
                    "text": "-1961",
                    "ref_id": null
                },
                {
                    "start": 3015,
                    "end": 3066,
                    "text": ", 1955, 1956t-1957t pregnancy and, 1967-1971, 2205-",
                    "ref_id": null
                },
                {
                    "start": 3067,
                    "end": 3130,
                    "text": "2019-2020, 2019t hemostasis and, 1832, 1832f, 1837, 1909, 1910f",
                    "ref_id": null
                },
                {
                    "start": 3202,
                    "end": 3206,
                    "text": "(TF)",
                    "ref_id": null
                },
                {
                    "start": 3220,
                    "end": 3414,
                    "text": "and, 1849 atherothrombosis and, 2129 cancer, thrombosis, and, 2250-2251 coagulation and, 1889, 1890f, 1903f disseminated intravascular coagulation and, 2064-2066 hemostasis and, 1907-1909, 1908f",
                    "ref_id": null
                },
                {
                    "start": 3415,
                    "end": 3436,
                    "text": "factor VIII and, 2002",
                    "ref_id": null
                },
                {
                    "start": 3437,
                    "end": 3442,
                    "text": "-2003",
                    "ref_id": null
                },
                {
                    "start": 3443,
                    "end": 3475,
                    "text": "factor VIII inhibitors and, 2025",
                    "ref_id": null
                },
                {
                    "start": 3476,
                    "end": 3481,
                    "text": "-2027",
                    "ref_id": null
                },
                {
                    "start": 3482,
                    "end": 3500,
                    "text": "functions of, 2051",
                    "ref_id": null
                },
                {
                    "start": 3501,
                    "end": 3526,
                    "text": ", 2052f genetics of, 2051",
                    "ref_id": null
                },
                {
                    "start": 3527,
                    "end": 3532,
                    "text": "-2052",
                    "ref_id": null
                },
                {
                    "start": 3533,
                    "end": 3561,
                    "text": ", 2053f hemostasis and, 1832",
                    "ref_id": null
                },
                {
                    "start": 3562,
                    "end": 3567,
                    "text": "-1834",
                    "ref_id": null
                },
                {
                    "start": 3568,
                    "end": 3574,
                    "text": ", 1839",
                    "ref_id": null
                },
                {
                    "start": 3575,
                    "end": 3580,
                    "text": "-1840",
                    "ref_id": null
                },
                {
                    "start": 3581,
                    "end": 3594,
                    "text": ", 1839t, 1907",
                    "ref_id": null
                },
                {
                    "start": 3601,
                    "end": 3625,
                    "text": ", 1910f in neonate, 2189",
                    "ref_id": null
                },
                {
                    "start": 3626,
                    "end": 3662,
                    "text": "platelet adhesion and, 132-133, 1872",
                    "ref_id": null
                },
                {
                    "start": 3730,
                    "end": 3745,
                    "text": "Vorapaxar, 2164",
                    "ref_id": null
                },
                {
                    "start": 3746,
                    "end": 3752,
                    "text": ", 2173",
                    "ref_id": null
                },
                {
                    "start": 3753,
                    "end": 3783,
                    "text": "Vorinostat, 875-876, 967, 1357",
                    "ref_id": null
                },
                {
                    "start": 3784,
                    "end": 3789,
                    "text": "-1359",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Renal transplantation",
            "authors": [],
            "year": 1997,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1441--1442",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Renin-angiotensin system (RAS)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1073--1074",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Replication-competent retroviruses (RCR)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Reptilase time",
            "authors": [],
            "year": 1927,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "2039--2040",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "See Drug resistance Respiratory burst pathway",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Resistance",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Respiratory syncytial virus (RSV), 1678 Responsive elements, 20 Restriction endonucleases",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Reticular dysgenesis (RD)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "371",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Reticulocyte count, 460t, 463, 464t",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Retinoic acid syndrome",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Retinoic acid-related orphan receptor (ROR) family",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Revascularization therapies",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "2165--2166",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Reverse cholesterol transport (RCT) pathway",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "2123--2124",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Revesz syndrome",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "365--367",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Revised European Classification of Lymphoid Neoplasms (REAL Classification",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Restriction fragment length polymorphism Rh deficiency syndrome",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Rflp",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "RhAG blood group system",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "RhCE protein",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1696--1697",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Rhesus blood group system",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1696--1697",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "RhD) overview of, 1696-1697, 1696b passive immunization and, 277 platelet transfusions and, 1717-1718 RhIG and",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Rhesus",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Rh-negative blood group",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "See Small nuclear ribonucleoproteins Ribosomal protein S19 (RPS19)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ribonucleoproteins",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "373--374",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Richter syndrome (RS)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "827",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Ring chromosomes",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Rickettsia Spp",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Ring sideroblasts",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Ristocetin-induced platelet aggregation (RIPA) assay",
            "authors": [],
            "year": 1928,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "for extranodal marginal zone lymphoma of MALT type, 1282 for follicular lymphoma, 1294t, 1295-1296 for hairy cell leukemia, 1272-1273, 1273t, 1275 for hemophilia, 2031-2032 HIV and lymphoma and, 1328 nuclear hormone receptor superfamily and, 72 overview of in hematopoiesis, 68, 69f, 69t phosphatidylinositol-3-kinase. See Phosphatidylinositol-3-kinase protein-tyrosine kinases and associated receptors",
            "authors": [],
            "year": null,
            "venue": "Rituximab for acute lymphoblastic leukemia, 1039, 1047 for antiphospholipid syndrome, 2100 for chronic lymphocytic leukemia, 1254-1256 for EBV-lymphoproliferative disease",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "See TGF-\u03b2 signal transduction pathway through adhesion molecules, 132 toll-like receptors and, 71 tumor necrosis factors and, 71 wnt proteins and",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Tgf-\u0392 Pathway",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "71--72",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Signaling inhibitors",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "862",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Signal-sensing domains",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Simian immunodeficiency virus",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Single nucleotide polymorphisms (SNP)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "12",
            "issn": "",
            "pages": "779--780",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Single unit cord blood transplantation (SCBT) adult donor allograft vs., 1635, 1636t double-unit cord blood transplantation vs., 1640-1645 engraftment and, 1633 graft versus host disease and, 1633-1634 relapse and, 1634 transplant-related mortality and survival",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Single-cell sequencing",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Single-nucleotide variants (SNV)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Sink model",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Sinus histiocytosis with massive lymphadenopathy (SHML)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Sinusoidal obstruction syndrome (SOS)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "717",
            "issn": "",
            "pages": "1676--1677",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Small interfering RNAs Sirolimus, 1659",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Six transmembrane epithelial antigen of the prostate",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Sj\u00f6gren syndrome",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "684--685",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Skin antiphospholipid syndrome and, 2098 graft-versus-host disease and, 1651-1652, 1651f, 1651t, 1660-1661 hypereosinophilic syndrome and, 1161 infection and, 1451 myelodysplastic syndromes and, 955 sickle cell disease and, 604-605 Skin cancer",
            "authors": [
                {
                    "first": "X-Inactivation",
                    "middle": [],
                    "last": "Skewed",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Pattern",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Skin necrosis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Systemic lupus erythematosus SleX",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sle",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "Small interfering RNAs (siRNAs), 11, 11f, 20-22 Small intestine",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "531--532",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "See Chronic lymphocytic leukemia Small nuclear ribonucleoproteins (snRNP",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Small-vessel disease",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Smooth muscle myosin heavy chain Smoking",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Smmhc",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "677",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Smoldering multiple myeloma (SMM)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1381",
            "issn": "",
            "pages": "1400--1401",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Smoldering systemic mastocytosis (SSM), 1173-1174 Smooth muscle",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Smooth muscle myosin heavy chain (SMMHC)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "SMPD1. See Sphingomyelin phosphodiesterase 1 SMZ lymphoma (SMZL)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "669",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "See Soluble NSF association protein receptors snRNP. See Small nuclear ribonucleoproteins SNS032",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Snares",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Sodium butyrate",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Solid organ transplantation. See Organ transplantation Solitary plasmacytoma",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1401--1402",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Solubility tests for hemoglobin",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Soluble intercellular adhesion molecule I (sICAM-1)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Soluble NSF association protein receptors (SNAREs)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "Soluble transferrin receptors (sTFR)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "493",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "See also Ferroportin Solvent-detergent (S-D) plasma",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "Somatic gene therapy",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Somatic genomic variants, defined",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "Somatic hypermutation (SHM; affinity maturation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "219",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Somatic mutations, germline variants vs",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "Sonic Hedgehog (SHH) pathway, 1299, 1300f Sons of mothers against decapentaplegic (SMAD)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "474",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "Source plasma, overview of",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1745",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF91": {
            "ref_id": "b91",
            "title": "Southeast Asian ovalocytosis (SAO), 640, 646 Southern blotting",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "13--14",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "Specialized lineage model of dendritic cells, 247 Specific granule deficiency (SGD), 707 X Xanthine oxidase",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "See also Factor IXa; Factor VIIIa X-box binding protein 1 (XBP1)",
            "authors": [],
            "year": 1907,
            "venue": "Xase complex",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "X-chromosome clonal assays",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "782--783",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "Xenotransplantation assays",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "Xenotropic murine leukemia virus-related virus (XMRV)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "Xerocytosis, hereditary, 644-645 XIAP deficiency",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "753--754",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "X-linked \u03b2-thalassemia",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "344",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "X-linked dyserythropoietic anemia",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "343--344",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "X-linked gray platelet syndrome",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF101": {
            "ref_id": "b101",
            "title": "X-linked inhibitor of apoptosis (XIAP)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "190",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "X-linked lymphoproliferative syndrome (XLP)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "733",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "X-linked lymphoproliferative (XLP) disease",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "X-linked severe combined immunodeficiency",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1552--1553",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "Venous thromboembolism (VTE) (Continued)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "X-linked sideroblastic anemia",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "498",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "X-linked sideroblastic anemia with cerebellar ataxia (XLSA/A)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "508--509",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF3": {
            "text": "activation factor (BAFF), 722, 1245, 1259 B-cell acute lymphoblastic leukemia (B-ALL)",
            "latex": null,
            "type": "table"
        },
        "TABREF9": {
            "text": "Congenital bone marrow failure syndromes. See Bone marrow failure syndromes, inherited Congenital disorder of glycosylation type II. See Churg-Strauss syndrome CTL. See CD8+ cytotoxic T cells; Choline transporter-like protein; Cytotoxic T lymphocytes CTLA4. See Cytotoxic T lymphocyte antigen 4 CTLR. See C-type lectin receptors CTPS1. See Cytidine triphosphate synthase 1",
            "latex": null,
            "type": "table"
        },
        "TABREF12": {
            "text": "See Epigallocathechin-3-gallate Egr-1. See Early growth response protein 1 Ehrlichia spp., 1815 EIF. See Eukaryotic initiation factors EKLF. See Erythroid Kr\u00fcppel-like factor ELANE.",
            "latex": null,
            "type": "table"
        },
        "TABREF14": {
            "text": "Functional plasticity model of dendritic cells, 247 Fungal infections, 1455-1456, 1456b, 1460, 1674-1675. See also Specific fungal infections FUS/ERG fusions, 804 FUT. See Fucosyltransferases FVIII. See Factor VIII FXIII deficiency. See Factor XIII deficiency FY. See Duffy antigen CSF. See Granulocyte-macrophage colony stimulating factor GO (anti-CD33 antibody) therapy, 938 Gold, 401, 1965 Goldie and Coldman hypothesis, 849-850 Golgi apparatus, 55-56. See also Trans-golgi network Gonadal dysfunction, 1228, 1499-1500 Good syndrome, 686-687 Good tissue practices (GTP), 1537 Goodpasture disease, 1787 GP Ib-IX-V complex. See under Glycoproteins GP IIb/IIIa. See under Glycoproteins GPI anchor. See Glycosylphospatidylinositol anchor G-protein coupled receptors (GPCR) human leukocyte antigens and, 1731 mesenchymal stromal cells and, 1562, 1565b natural killer cells and, 1578, 1580f, 1581 overview of, 1650, 1680 pain and, 1482 peripheral blood stem cells and, 1517, 1518b single vs. double unit cord blood transplantation and, 1640-1641 transfusion-associated, 1663, 1703, 1706, 1798, 1798b Graft-versus-leukemia (GVL) effect allogenic HSCT and, 1601-1604 chimeric antigen receptor T cells, cytokine release syndrome and, 1664-1667 in chronic myelogenous leukemia, 1068 clinical features of, 1664 donor lymphocyte infusion and, 1568-1569 future directions, 1667 genetic basis of, 1664 haploidentical hematopoietic stem cell transplantation and, 1618-1620 Schwachman-Diamond syndrome, 364 treatment of acute lymphoblastic leukemia and, 1037 Granulocyte-macrophage colony stimulating factor (GM-CSF) for aplastic anemia, 413 dendritic cells and, 258 eosinophilopoiesis and, 1156-1157 for Fanconi anemia, 359-360 graft failure and, 1676 mobilization of hematopoietic stem cells and, 1523 for myelodysplastic syndromes, 963 neutrophil maturation and, 323-324, 324f treatment of acute lymphoblastic leukemia and, 1037 Granulocytes. See also Basophils; Eosinophils; Neutrophils See G protein-coupled receptor kinase 3 Growth and differentiation factors (GDF), 70, 475-476, 475f Growth factor independent 1 (Gfi-1), 328, 346 GSI. See \u03b3-Secretase inhibitors GTPases, 135-136, 1873 GTX. See Neutrophil transfusions Guanine nucleotide exchange factors (GEF), 45-46 Guglielmo, Givanni di, 944 Guillain-Barr\u00e9 syndrome, 1755 Gum bleeding, 1915 Haplotypes, defined, 80-81, 1617 HapMap project, 80-81, 80t Haptoglobin (Hp), e4b, e16t Haptotaxis, 138-139 HARP, 642 Hartwell, Leland, 178 HAS-BLED scoring system, 2155t, 2156-2157 HCP. See Src homology containing phosphatases HDACi. See Histone deacetylase inhibitors HDL efflux capacity, 2124 Hearing, 1501-1502 Heat denaturation, 665 Heat shock protein inhibitors, 878 Heat stroke, 2068 Heavy chains, 212, 213f Heavy metal exposure, 401 Hedgehog (Hh) signaling, 72, 101 Heiner syndrome, 2223-2225 Heinz bodies, 610-611, 611f \u03b1-Helices, 59, 60f-61f Helicobacter pylori, 1280-1281, 1283b HELLP syndrome, 1999, 2069, 2206-2207 Helper T cells. See T helper cells sinusoidal obstruction syndrome, 1676-1677, 1676b conditioning regimens for, 1593 for Diamond-Blackfan anemia, 379 donor selection and evaluation, 1517-1519, 1518b for dyskeratosis congenita, 368 evaluation of manipulated grafts and, 1540-1542 for Fanconi anemia, 358-359 future directions, 1594 genetic testing for, 846b haploidentical. See Haploidentical hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis, 736-737 infection management and, 1457-1460, 1457f for Kostmann syndrome/severe congenital neutropenia, 388-389 manipulation of products, 1538-1540, 1538t for mastocytosis, 1184-1185 mesenchymal stromal cells and, 1563-1564 natural killer cells and, 1578 neurocognitive complications of, 1501 osteonecrosis and, 1500 overview of, 1517-1518, 1591, 1592t pediatric transfusions and, 1826 professional standards for, 1538 psychosocial considerations, 1464-1466 pulmonary complications and, 1498 for pure red cell aplasia, 430 quality control of cell products, 1527-1529 regulatory issues with cell processing and, 1537-1538, 1543f for Schwachman-Diamond syndrome, 364-365 selection of product used in, 1518b for severe combined immunodeficiency, 713-714 sources of stem cells used in, 1593 thrombotic microangiopathies following, 1997 Hematopoietic stem cells (HSC) aplastic anemia and, 394-396 cell division cycle and, 184 chemokines and migration to bone marrow and mobilization and niche, 140-141 development and, 119 embryonic origin of, 95 functional assays, 98-99, 99f gene therapy and, 1549 generation from pluripotent stem cells and reprogramming of somatic cells, 107 homing of, 145-146, 146f, 150b-151b human, 96f, 97-98 JAK2V617F mutation, polycythemia vera and, 1085-1086 malignancy and, 108-109, 109f metabolism of, 105 mobilization of, 146-150, 150b-151b murine, 95-96, 96f-97f novel growth factors for, clinical testing and, 106-107 overview of, 95 phenotype, 95-98, 96f-97f regeneration of, 107-108 regulation of fate extrinsic, 100-101 intrinsic pathways, 101-105, 102t thrombopoietin signaling in, 339 Hematopoietic zinc finger (Hzf ), 1864 Hematopoietins, 163, 164f. See also Cytokines, class/type I Hemoglobin S solubility test, e4b Hemoglobin sickle cell disease, 606 \u03b1-Hemoglobin stabilizing protein (AHSP), 303 Hemoglobin-based oxygen carriers (HBOC), 1712",
            "latex": null,
            "type": "table"
        },
        "TABREF20": {
            "text": "See Low-density lipoprotein receptor-related proteins LSC. See Leukemic stem cells LTC-IC assay. See Long-term culture initiating cell assay Mature B-cell acute lymphoblastic leukemia. See Burkitt lymphoma May-Hegglin anomaly, 1862-1863, 1883 MBL. See Monoclonal B-cell lymphocytosis MBP. See Major basic proteins MCAHS2. See Multiple congenital abnormalities-",
            "latex": null,
            "type": "table"
        },
        "TABREF29": {
            "text": "linked, 498f, 507-508, 508f overview of, 506-507 presentations associated with, 511-512 Sidney Criteria for antiphospholipidsyndrome, 2088syndrome,  ,  2089t  Siglecs, 131, 1167. See also CD33 Sign R1, 261 Signal recognition particle (SRP), 51, 51f Signal transducers and activators of transcription(STAT).See also Janus-activated kinase-STAT pathway B cell development and, 217 consequences of deficiencies in genes of,173t, 718 erythropoietin receptors and, 1073 hepcidin expression and, 476 hyperimmunoglobulin E syndrome and, 704 immune dysregulation and, 718-719 neutrophil maturation and, 323 overview of, 70, 168f, 169 See Janus kinases ligand-receptor binding and activation, 164-173, 167f negative regulators of cytokine signaling, 171-173 physiology and pathology, 173-174, 173t erythropoietin receptors and, 305-307, 306t G-protein coupled receptors and, 72 hedgehog, 72, 101 MAPK/ERK pathway, 70, 865 myelodysplastic syndromes and, 966 notch ligands and, 72 See Splenomegaly functional tests for, 2320-2321 hairy cell leukemia and, 1268, 1268f hemolytic anemia and, 666, 666t hypersplenism and. See Hypersplenism imaging of, 2319-2320 immune cell development and, 203 infection and, 1451 infectious mononucleosis and, 752, 752f malaria and, 2280, 2284 neutrophilia and, 677 overview of, 208-209, 208f primary myelofibrosis and, 1143-1145 sickle cell disease and, 587f Src homology 2 domain protein 1A (SH2D1A), 753 Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 (SHPS-1), 449 Src homology containing phosphatases (SHP), 171-172, 173t, 1073 SRSF2, 21, 948 SRY-box 11 (SOX11), 1298-1301, 1306 ST2 biomarker, 1658 STAT proteins. See Signal transducer and activator of transcription proteins Statins, 1938, 2122, 2123f, 2140, 2165-2166 STE6, 879 Stem cell factor (SCF; Kit ligand) erythropoiesis and, 298, 307, 316 homing of hematopoietic stem and progenitor cells and, 146 mast cell development and, 1171 megakaryocyte development and, 334 Stem cell leukemia (SCL, TAL1), 103, 314, 316, 346, 840, 1008, 1013 Stem cell leukemia/lymphoma syndrome, 790, 1162-1163 Stem cell niche. See Niche theory Stem cell transplantation for chronic lymphocytic leukemia, 1249b, 1259 for cutaneous T-cell lymphomas, 1375 hematopoietic. See Hematopoietic stem cell transplantation for light chain amyloidosis, 1439f, 1440-1441, 1441f for paroxysmal nocturnal hemoglobinuria, 422 for peripheral T-cell lymphomas, 1355-1357 for sickle cell disease, 591 Stem cells. See also Specific types erythroid differentiation and, 299f, 300 leukemia, 921 myelodysplastic syndromes and, 947 paroxysmal nocturnal hemoglobinuria and, 417, 419 proleukemic, 114b as source of red blood cells, 1713 spleen and, 2318 StemRegenin 1 (SR1), 106, 1647 Stenting, 2138-2139, 2147b Steroid hormones, 72 Steroids. See Corticosteroids Sterol hormones, 72 Sterol regulatory element-binding protein (SREBP), 2122 Sterol response elements (SRE), 2122 Stiff-person syndrome, 1756 Stomatocytosis, 626, 644-645, 669 Streptococcus pneumoniae, 597-598, 1998 Streptokinase, 2110, 2142-2143, 2143t, 2184-2185, Stromal cell-derived factor 1 (SDF1), 122, 145-149, 149f, 1845 Str\u00fcbing, Paul, 415 Structural genomic variants, overview of, 81 Structural maintenance of chromosomes (SMC), 920 ST-segment elevation myocardial infarction (STEMI), 2142 Stuart-Prower factor, 2043 Stypven clotting time, 1941 Subarachnoid hemorrhage (SAH), 2133, 2135 Subcutaneous panniculitis-like T-cell lymphoma (SPTCL), 1198-1199, 1199f, 1367 Subdural hemorrhage, 1917 Signal transduction pathways (Continued) Subsequent malignancies. See Second/subsequent malignancies Substrate reduction therapy (ART), 742-744 Sucrose hemolysis test, 420 Sudden death, 582 Suicide genes, 1544-1545, 1572-1573 Sulfadoxine-pyrimethamine, 2287t Sulfasalazine, 538b Sulfation, 47 Sumoylation, 47, 104 Sunitinib, 991 Superenhancers, 17, 18f, 1013, 1013f Superoxide anions, 74-75, 1853 Supertransfusion, 553 Supervised learning approaches, 26, 26f Supplements, 2254, 2255t, 2258-2260 Support groups, 1470, 1471t Suppressor of cytokine signaling (SOCS), 172-173, 173f, 173t, 1073 Surface-connected canalicular system, 131-132 Switch/sucrose nonfermentable (SWI/SNF), 20, 23 Sympathetic innervation, 122 Synaptosomal-associated protein (SNAP), 1876, 1876f-1877f Syndesmos, 1844 Syngenic transplantation, 1411 Syphilis, 1458, 1814 Systemic juvenile idiopathic arthritis (sJIA), 2219-2221 Systemic lupus erythematosus (SLE) P13K-ATK pathway in, 1014-1015 RPL genes in, 1017 TAL1, LMO genes in, 1008, 1013 therapy, 1025-1026 T cell acute lymphocytic leukemia 1 (TAL1). See Stem cell leukemia T cell antibodies, 1659 T cell exhaustion, 232-233 T cell lymphomas allogenic HSCT for, 1606 classification of, 1196-1202, 1196b cutaneous. See Cutaneous T-cell lymphomas overview of, 1188t peripheral/noncutaneous. See Peripheral T-cell lymphomas T cell lymphoproliferative neoplasms, 840-845 T cell receptor excision circles (TREC), 712-713 cell therapies with activated T lymphocytes. See Activated T lymphocytes with cytotoxic T lymphocytes. See Cytotoxic T lymphocytes for EBV-lymphoproliferative disease, 757 future directions, 1573 genetic modification in, 1570-1573, 1570f overview of, 1568 T cell/histiocyte rich-type large B-cell lymphoma (THRLBCL), 1193 T cell-mediated immunity, 231-235, 234f T cells activation of, 221-226, 222f-223f, 1542-1544 adhesion of to antigen-presenting cells, 133, 133f chimeric antigen receptors and. See Chimeric antigen receptor T cells complement and immunity, 272, 272f dendritic cells and activation of, 252-254, 253t development of, 226-229 disorders with immune dysregulation mediated by, 717-719 dominance in double-unit cord blood transplantation and, 1637-1638 Epstein-Barr virus and, 750, 754t functions of, 229-231 genetic modification of, 1570-1573 graft-versus-host disease and, 1655-1657, 1662 graft-versus-leukemia responses and, 1665-1666 hematopoietic stem cell processing and, 1539-1540, 1540t Hodgkin lymphoma and, 1206 human leukocyte antigens and, 1732 inhibition of immunity mediated by, 233-235, 236f lymphomas of, 1188t, 1196-1202, 1196b manipulating to improve activity against malignancy, 237-238 maturation of, 204 maturation of immunity mediated by, 231-233 migration of to T zones, 141-142 modulating to permit allograft transplantation, 237 multiple myeloma and, 1390 nonspecifically activated autologous, 1542-1544 overview of in immune system, 202-203 proliferation of, 226 regulatory. See Regulatory T cells SCID and early defects in development of, 710-714 self-tolerance and, 286, 287f therapeutic manipulation of immunity mediated by, regulatory cells. See Regulatory T cells T zones, 141-142 T3151 mutation, 1064-1065 Tacrolimus, 1659, 1661t, 1664, 1997 TAFI. See TATA-box binding protein associated factor 1 TAL1. See Stem cell leukemia TAL2. See T-cell acute leukemia 2 TALENs. See Transcription activator-like effector nucleases Tamoxifen, 2083 Tandem repeats, overview of, 12 Tanespimycin, 878 Tank treading, 666 TAP. See Transporter associated with antigen processing Tapeworms, 2303 TAR syndrome. See Thrombocytopenia absent radii syndrome Target-specific oral anticoagulants (TSOAC), 1930 Tartrate-resistant acid phosphatase (TR-ACP), 1266-1268 TATA-box binding protein associated factor 1 (TAFI), 1839 Tax, 1322-1323 Taxanes, 856-858, 880 Taxol. See Paclitaxel Taxotere. See Docetaxel TAZ gene, 390 T-box transcription factor TBX21 (T-bet), 230-231 TCA cycle. See Tricarboxylic acid cycle T-cell chronic lymphocytic leukemia, 843 T-cell depleted (TCD) stem cell grafts, 1623-1624, 1623f TERC. See Telomerase RNA component Terminal deoxynucleotidyl transferase (TdT), 212-214 TERT. See Telomerase reverse transcriptase Testis, 1193 Testosterone, 412-413, 1080 TET. See Ten-eleven translocation Tetramer analysis, 1541, 1541f Tetrameric HLA/epitope complexes (tHLA), 1721, 1732, 1733f Tetrocarcin A, 872 TG. See Thioguanine TGF-\u03b2. See Transforming growth factor beta TGN. See Trans-golgi network Th cells. See T helper cells helper-inducing POZ/Kr\u00fcppel-like factor (Th-POK), 228 Therapeutic plasma exchange (TPE), 1790-1791. See also Thomas, E. Donnall, 1515 Thomsen-Freidenreich (T-F) antigen, 1998 Thorotrast, 1125 Thrombate III, 1766 Thrombelastography (TEG), 2071 Thrombin cancer, thrombosis, and, 2251 developmental hemostasis and, 2189-2190 disseminated intravascular coagulation and, 2065-2066 endothelial cells and, 1851-1852 endothelial permeability and, 1851 hemostasis and, 1906, 2189-2190 platelet adhesion and, 1872 protein C pathway and, 2078, 2078f surgical patients and, 2306 Thrombin clotting time (TCT),1925-1927 , 1927t  Thrombin concentrate, 1110 , 1766 Thrombin generation assays (TGA), 1929 Thrombin-activatable fibrinolysis inhibitor (TAFI),1898,  1899f, 1904, 2040  Thrombin-JMI, 1766 Thrombocytes. See Platelets Thrombocytopenia with absent radii (TAR) syndrome",
            "latex": null,
            "type": "table"
        },
        "TABREF30": {
            "text": "See Idiopathic thrombocytopenia purpura immune-mediated, 2231-2232, 2232binfections and, 441-442 infectious mononucleosis and, 752 inherited, 347b, 347t-348t, 1883-1884, 2193 inherited bone marrow syndromes with, 369t,",
            "latex": null,
            "type": "table"
        },
        "TABREF31": {
            "text": "Thromboxane receptor, 1833-1834, 1873  Thromboxanes, 1833-1834, 1988-1991, 2169f,  21702171 Thymic regulatory T cells (tTregs), 228, 233 Thymic settling progenitors (TSP), 227 Thymidine kinase, 1250 Thymidylate deficiency, 522-523 Thymoma, 426 Thymus, 204, 227-228, 227f, 710 Thyroid cancer, 1503-1504 Thyroid disorders, 1498-1499, 2225 Thyroid hormones, 72 Tibetans, 1077 Ticagrelor, 2145t, 2146, 2171 Tick-born bacterial infections, 1815-1818 Ticlopidine, 1935, 2164 Tie receptors, 153-154, 1848 Tight junctions, 1844-1845 TIL. See Tumor-infiltrating lymphocytes Tip cells, 1846-1847 Tirofiban for acute coronary syndromes, 2146-2147, 2146t overview of, 2172-2173, 2172t platelet disorders and, 1936 thrombocytopenia and, 1966 TISSEEL, 1766 Tissue factor pathway inhibitor (TFPI) coagulation and, 1892-1893, 1901 disseminated intravascular coagulation and, 2065, 2066f, 2067 endothelial cells and, 1852 factor V deficiency and, 2041 for hemophilia,",
            "latex": null,
            "type": "table"
        },
        "TABREF32": {
            "text": "Tissue necrosis factors (TNF), 202t Tissue pillars, 1846 Tissue plasminogen activator (tPA) See Toll-like receptors TLX genes, 1008-1009 T-lymphoblastic leukemia/lymphoma (T-ALL), 772 TNF receptor 1-associated periodic syndrome (TRAPS), 688, 1432 TNFAIP3, 1419, 1421 TNFR1, 194 TNFR-associated factor (TRAF) receptors, 71 TNFRSF14 genes, 1288-1290, 1289t Tocilizumab, 1659 Tocopherols, 2126 Tolerance, 254-256. See also Self-tolerance Tolerogenic dendritic cells (tDC), 254 Toll-like receptors (TLR) antiphospholipid syndrome and, 583, 2088-2089 atherothrombosis and, 2126 autoimmunity and, 291-292 dendritic cells and, 249-250, 250t innate immune system and, 199 mesenchymal stromal cells and, 1562 overview of, 71 self-reactive lymphocytes and, 288-289 Toluene, 1125 Topoisomerase I inhibitors, 858-860, 858t, 901 Topoisomerase II inhibitors acute myeloid leukemia and, 913 pharmacology of, 858t, 859-860, 859f, 860t, 899-901 Topotecan, 859-860, 859f, 901 Torcetrapib, 2124 TORCH syndrome, 370 Torque teno virus (TTV) complex, 1806 Total body irradiation (TBI), 1497 Total homocysteine, 526t, 527, 527b, 529b, e7b, e18t Total iron-binding capacity (TIBC), e5b Touch therapy, 2257, 2257t Toxic oil syndrome, 1164 Toxins, 292, 913-914, 2070 Toxoplasmosis, 683, 1458-1460, 1817, 2302 TP53 acute myeloid leukemia and, 919 Hodgkin lymphoma and, 1209 mantle cell lymphoma and, 1298-1299, 1300f multiple myeloma and, 831 myelodysplastic syndromes and, 951-953 Richter syndrome and, 827 TPMT. See Thiopurine S-methyltransferase TPST. See Tyrosyl-protein sulfotransferases Traditional Chinese medicine, 2253. See also Acupuncture Tranexamic acid for disseminated intravascular coagulation, 2074 factor replacement therapy and, 2039b for factor VIII inhibition, 2030-2031 for hemophilia, 1775, 2015 surgical patients and, 2306-2307 for von Willebrand disease, 2061 Trans-acting elements, defined, 9 Trans-activating domains (TAD), 20 Transcription, 18-19, 18f, 180-181, 180f Transcription activator-like effector nucleases (TALENS), RNA polymerases and, 17 specification of hematopoietic stem cells and, 103 Transcription-coupled nucleotide excision repair, 20 Transcutaneous electrical nerve stimulation (TENS), 1475 Transdermal fentanyl patch. See Fentanyl patch Transendothelial migration, 129, 138 e17t use of iron for erythropoiesis and, 469 Transforming growth factor beta (TGF-\u03b2) angiogenesis and, 1847f, 1848 \u03b2-thalassemia syndromes and, 551 erythropoiesis and, 312 graft-versus-host disease and, 1662 hematopoietic stem cell fate and, 101 limitation of T cell activity and, 235 multiple myeloma and, 1389 overview of in hematopoiesis, 70 Transfusion frequency, 978 Transfusion reactions after hematopoietic stem cell transplantation, 1800-1801, 1800t allergic, 1795-1796, 1796b febrile nonhemolytic. See Febrile nonhemolytic transfusion reactions hemolytic acute extravascular, 1794 acute intravascular, 1792-1794, 1793b-1794b delayed, 1794 serologic presentation, 1793t human neutrophil antigens and, 1736 hypotensive, 1796 infections. See Transfusion-related infections sickle cell disease and, 596-597 types of, 1793t Transfusion therapy acquired iron overload and, 487, 489 anemia of chronic diseases and, 494 for aplastic anemia, 406-407 for autoimmune hemolytic anemia, 656, 656b autoimmune hemolytic anemia after, 653 for \u03b2-thalassemia syndrome, 553-554, 553b-554b, 554f, 565t Diamond-Blackfan anemia and, 378 granulocyte. See Granulocyte transfusions hemolysis and, 667 for hemophilia A, 1769-1773, 1770t for hemophilia B, 1769-1773, 1770t for hereditary sideroblastic anemia, 509b for myelodysplastic syndromes, 962 neutrophil. See Neutrophil transfusions overview and historical perspective, 1515-1516 plasma derivatives. See Plasma derivatives plasma derivatives and, 1746-1747 platelet. See Platelet transfusions red blood cell. See Erythrocyte transfusion for sickle cell disease, 590-591, 591t for thrombocytopenia with absent radii syndrome, 389-390 for von Willebrand disease, 1776-1777 Transfusion-associated circulatory overload (TACO) overview of, 1798-1802 plasma transfusion and, 1749 Transfusion-associated graft versus host disease (TA-GVHD), 1663, 1703, 1706, 1798, 1798b Transfusion-related acute lung injury (TRALI), 1717, 1736, 1748-1749, 1797, 1797t Transfusion-related immunomodulation (TRIM), general indications and dosing, 1822-1824, 1822t technical considerations, 1822 unique populations, 1824-1827 Transgenic mice, 14-15 Trans-Golgi network (TGN), 52f, 56, 740 Transient abnormal myelopoiesis (TAM), 813, 915, 1001-1002 Transient erythroblastopenia of childhood (TEC), 377, 377t, 425, 460, 2220 Transient hypogammaglobulinemia of infancy, 688 Transient ischemic attack (TIA), 2096-2097, 2137 Transient myeloproliferative disorder (TMD), 1001-1002 Transitional B cells, 218 Translation, 10-11, 45-46, 878 Translocase of the outer membrane (TOM), 50 Translocases of the inner membrane (TIM), 50 Translocation liposarcoma (TLS), 20 Translocations, 28-29, 63-64, 1383-1384 Transmissible spongiform encephalopathies (TSEs), 1770-1771, 1818-1819 Transmucosal pain medication administration, 1479 Transplantation autoimmune hemolytic anemia in, 653 blood groups and, 1695 bone marrow. See Bone marrow transplantation cardiac, 1441-1442 cyclophosphamide and, 1625-1627, 1626f hematopoietic stem cell. See Hematopoietic stem cell transplantation homing and mobilization of hematopoietic stem and progenitor cells and, 150b-151b infection following, 1451-1457, 1452f kidney, 1441-1442, 1997 liver, 743, 1078, 2231, 2310-2311 organ. See Organ transplantation for relapsed indolent lymphomas, 1296 renal, 1441-1442, 1997 stem cell. See Stem cell transplantation thrombotic microangiopathies following, 1997-1999 Transporter associated with antigen processing (TAP), 879 Transporters. See Drug transporters Transposase-accessible chromatin assay, 29 Trans-repressive domains (TRD), 20 Trans-splicing, 20 Transthoracic echocardiography, 2137 Transthyretin (TTR; prealbumin), 1432 Trauma, 665, 1824-1825, 2068 Transcription factors (Continued) Treacher-Collins syndrome, 375 Tregs. See Regulatory T cells Trellis Peripheral Infusion System, 2115 Trephine biopsy sections, 1030, 1031f Treslin (TICRR), 181-182 Tretten, 1766 Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification system, 2133 Tricarboxylic acid (TCA) cycle, 74 Trichomonas spp., 1814 Tricyclic antidepressants (TCA), 1480 Trimethoprim, 538b Trimethyl amine (TMA), 2131 Trimethylation, 19-20 Triosephosphate isomerase (TPI), 622 Tripeptidyl-peptidase II (TPP2), 719 Triple negative essential thrombocythemia, 1112, 1114t Triple-hit lymphoma, 838f Tube gel test, 651, 651f Tubulins, 11, 346, 1861, 1865f, 1866-1868 Tumor cell contamination, 1528-1529, 1539 Tumor lysis syndrome (TLS), 88 Tumor microenvironment, 257 Tumor necrosis factor receptors (TNFR), 71, 1658 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), 253, 255f, 298 Tumor necrosis factors (TNF) aplastic anemia and, 398 dendritic cells and T cell activation and, 252, 253t disseminated intravascular coagulation and, 2064-2065 graft-versus-host disease and, 1653, 1658 inhibition of erythropoiesis and, 493 malaria and, 2282 multiple myeloma and, 1389 phenotypic diversity in sickle cell disease and, 583 Tumor node-metastasis (TNM) staging system, 1368, 1369t Tumor suppressor genes, 919 Tumor vaccines, 1546-1547 Tumor-associated antigens (TAA), 1568, 1570, 1664 Tumorigenesis, 108-109 Tumor-infiltrating lymphocytes (TIL), 1544 Tumors angiogenesis and, 159 dendritic cell function and, 256-259, 259f platelet disorders and, 1940 recognition of by natural killer cells, 1577 solid, 654 Tumor-specific antigens (TSA), 1568, 1570, 1664 26S Proteasome, 866, 867f TWIST2, 1251 Twisted gastrulation protein (TWSG1), 475-476, 475f, 551 Type 351 products, 1537, 1543-1544 Typhlitis, 1453 Tyrosine kinase inhibitors (TKI). See also Specific inhibitors for acute myeloid leukemia, 991 BCR-ABL1 and, 87 for chronic myelogenous leukemia, 787, 1061-1066, 1069b for hypereosinophilic syndrome, 1166-1167 for mastocytosis, 1183-1184 pharmacology of, 903-905 for Philadelphia chromosome-positive acute lymphoblastic leukemia, 1042-1046, 1044t-1045t platelet disorders and, 1938 Tyrosine kinase receptors (RTK), 951 Tyrosine kinases, 63-64, 132, 173t, 764, 764t Tyrosyl-protein sulfotransferases (TPST), 47 Tyrosyl-tRNA synthetase 2 (YARS2), 509 U2AF1, 949 Ubiquitin, 48 Ubiquitination, 20, 47, 104, 181 UCSC Genome Browser, 22, 22f UL16 binding protein (ULBP), 242 Ultrasonography, 2105, 2319 Ultrasound-assisted catheter-directed thrombolysis, 2116-2117 Umbilical cord blood transplantation (UCBT) for acute lymphoblastic leukemia, 1041 for acute myeloid leukemia, 974 advantages and disadvantages of, 1517 allogenic HSCT and, 1598-1600 collection of cells for, 1521 donor selection in, 1519 graft failure and, 1676 haploidentical hematopoietic stem cell transplantation vs., 1627 homing and mobilization of hematopoietic stem and progenitor cells and, 151 natural killer cells and, 1578 overview of, 1593 for primary myelofibrosis, 1145-1146 regulation of, 1537 as source of red blood cells, 1713 from unrelated donor adaptive immunotherapy, 1648 cord blood vs. adult, 1635, 1636t double unit, 1635-1638, 1637t double vs. single unit, 1640-1645 future directions, 1648 novel strategies to enhance engraftment, 1645-1648, 1646t overview, 1633 single unit, 1633-1635, 1636t unit selection, 1639-1640, 1639f Unc-51 like autophagy activating kinase 1 (ULK1), 194-195 Unexplained anemia in the elderly, 1347-1348, 1355b, 2329, 2329b Unfolded protein response (UPR), 55, 195, 329 Unfractionated heparin (UFH), 2108-2109, 2199-2200 Uniparental disomy, 783-784 Unique long (UL) 16-binding proteins (ULBP), 1575 Unrelated donor hematopoietic stem cell transplantation. See under Allogenic hematopoietic stem cell transplantation Unspecified peripheral T-cell lymphoma, 843 Untranslated regions, 9, 20 Upfront intensified therapy, 1304-1305 Upshaw-Sch\u00fclman syndrome, 1986 Uracil DNA glycosylase (UNG), 687-688, 722-723 Urelumab, 1586 Uremic bleeding, 1750, 2244 Urinary tract infections (UTI), 598 Urokinase, 2110 Urokinase-type plasminogen activator (u-PA), 1832, 1839, 1897, 2184 UVA-1 phototherapy, 1370 Valvular heart disease, 1971 Vancomycin, 1962, 1964f Variable (V) gene segments, 212, 213f Variable number of tandem repeats (VNTR), 12 Variant Creutzfeldt-Jakob disease (vCJD), 1812b, 1818-1819 Varicella-Zoster virus (VZV), 1455, 1458-1459, 1673-1674, 1810 Variegate porphyria, 498f, 503, 503f Vascular cell adhesion molecules (VCAM) B cell development and, 216-217 cell adhesion and, 129 erythroid cell development and, 302 erythropoiesis and, 310 foam cell formation, fatty streak and, 2126 leukocyte entry into tissues and, 138 primary myelofibrosis and, 1129-1131 Vascular cooption, 159 Vascular endothelial cadherin (VE-cadherin), 155, 1844 Vascular endothelial cells. See Endothelial cells (vascular) Vascular endothelial growth factors (VEGF) angiogenesis and, 159, 1847f, 1848 angiogenic sprouting and, 158 multiple myeloma and, 1389 myelodysplastic syndromes and, 965 vascular system and, 153 Vascular endothelial growth factors (VEGF) inhibitors, 1849 Vascular occlusion, 578-581 Vascular system. See also Angiogenesis; Vasculogenesis elements of angiogenesis stimulators and inhibitors, 156, 156f angiopoietins and tie receptors, 153 cells, 152, 153f endothelium, 1831-1832, 1832f ephrins and Eph receptors, 154 integrins, cadherins, and cell adhesion molecules, 154-155 molecular regulators, 152-156, 154t Notch pathway, 153-154 overview, 152 platelet-derived growth factors, 153 prokineticins, 153 proteases, 155-156 vascular endothelial growth factors, 153 protective mechanisms for, 2103 Vascular tone, 1852-1853 Vasculogenesis, 152, 156-159, 157f, 1845-1846 Vasculogenic mimicry, 157f, 159 Vatalanib, 965 Vav1, 225 Vector of HLA incompatibility, 1611 Vel blood group system, 1700 Velban. See Vinblastine Venetoclax, 1258-1259 Venography, 2105 Venoms, 669, 2070 Venous compression ultrasonography, 2105 Venous stasis, 2102-2103 Venous thromboembolism (VTE). See also Deep vein thrombosis; Pulmonary embolism acquired assisted conception, ovarian hyperstimulation syndrome and, 2083 cancer and its treatment and, 2081-2082 heparin-induced thrombocytopenia. See Heparininduced thrombocytopenia hormonal therapy and, 2083 lupus anticoagulants, antiphospholipid syndrome and, 2080-2081 myeloproliferative disorders and, 2082 overview, 2077t paroxysmal nocturnal hemoglobinuria, 2082 paroxysmal nocturnal hemoglobinuria and, 419 pregnancy and, 2082-2083 prior history of VTE and, 2083-2084 acute recurrent, 2107-2108 cancer-associated, 2111 clinical presentation, 2084 combined inherited and acquired, 2084 diagnosis of, 2104-2105, 2106f, 2107-2108 HIV infection and, 2276 hypercoagulable states and, 2103 inherited antithrombin deficiency, 2076-2078 factor V Leiden gain-of-function mutation,2079 -2080   FIIG20210A mutation and, 2080   miscellaneous, 2080   overview, 2076 , 2077t  protein C deficiency, 2078 -2079 , 2078f, 2078t  protein S deficiency, 2079 , 2079t  laboratory evaluation of, 2084 -2085 , 2084b   long-term complications of, 2104   management of, 2085 -2086 , 2086t  mechanical interventions in, 21172120 mechanisms of, 2102-2103 natural history of, 2103 overview of, 1841, 2102 pathogenesis and clinical risk factors of, 2102 Vascular cell adhesion molecules (VCAM) (Continued) pregnancy and, 2110-2111, 2211-2212 prognosis of, 2104 prophylaxis of, 2108-2109 protective mechanisms, 2103 screening for, 2084, 2085b surgical patients and, 2312 treatment of, 2109-2110 Ventilation/perfusion (V/Q) lung scans, 2106-2107 Vepesid. See Teniposide Verbal rating scales (VRS), 1474 Vertebroplasty, 1475 Very late antigens (VLA), 125, 216-217, 310, 1129-1131 Vesicle-associated membrane proteins (VAMP), 1876, 1876f-1877f Vesicular stomatitis virus (VSV), 1551 Vessel wall, 1843-1855, 1847f, 1851f VHL-interacting deubiquitinating enzymes, 1072-1073 Vicenza variant of type 1 von Willebrand disease, 2056 Vinblastine, 856-858, 890 Vinca alkaloids, 856-858, 880, 1482 Vincristine for acute lymphoblastic leukemia, 1037, 1039, 1050 for hypereosinophilic syndrome, 1166 for multiple myeloma, 1402-1403 peripheral neuropathy and, 1482 pharmacology of, 856-858, 890 for Waldenstr\u00f6m macroglobulinemia, 1427-1428 Vindesine, 856-858 Vinorelbine, 856-858, 890-891 Viral capsid antigen (VCA) antibodies, 749-750, 750t Viral infections. See also Specific viruses after hematopoietic stem cell transplantation, 1673-1674 cytotoxic T lymphocytes specific for, 1569 dendritic cell function and, 256 disseminated intravascular coagulation and, 2068 natural killer cells and, 1579 neutropenia, lymphopenia and, 1455 neutropenia and, 432-433 plasma derivatives and, 1759-1760 pure red cell aplasia and, 425-427 sickle cell disease and, 595t thrombocytopenia and, 441-442 Viruses, 3 Virus-specific cytotoxic T lymphocytes (VST), 1569 Visceral leishmaniasis (VL), 2289-2292 Viscoelastic assays, 1929 Vision, 1501 Visual analog scales (VAS), 1474 Vitacel, 1766 Vitamin B deficiency, 2203-2204, 2270-2271 Vitamin B 12 . See Cobalamins Vitamin B 2 . See Folates Vitamin D 3 supplements, 2259 Vitamin K antagonist (VKA) therapy for atrial fibrillation, 2155 for disorders of hemostasis and thrombosis, 1841 heparin-induced thrombocytopenia and, 1981 Vitamin K-dependent (VKD) clotting factors coagulation and, 1885-1888, 1889f factor IX. See Factor IX factor VII. See Factor VII factor X. See Factor X overview of, 1765t protein C. See Protein C protein S. See Protein S protein Z. See Protein Z prothrombin. See Prothrombin Vitamin K-dependent (VKD) protein combined deficiencies, 2048-2049 Vitamin supplementation, 590 Vitronectin, 127 VKOR. See Vitamin K epoxide reductase VLA. See Very late antigen VNTR. See Variable number of tandem repeats Vogel, Friedrich, 81-82 Volume reduction, 1538-1539, 1827 Vomiting. See Nausea and vomiting Von Hippel-Lindau (VHL) syndrome, 1072-1073, Willebrand factor activity assay, 1928 von Willebrand factor antigen test, 1928, 2059 von Willebrand factor concentrates, 1761, 1764t, 1766, 1777, 2062 von Willebrand factor multimer analysis, 1928, 2055f, 2059 von Willebrand factor propeptide/antigen ratio, 2059-2060 von Willebrand factor receptor, 1867-1868, 1867f von Willebrand factor (vWF) ABO blood groups and, 2055",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": " Novastan, 1979 -1980 , 1979t-1980t NovoSeven, 1766 2117 Ruxolitinib, 865-866, 905, 1102 , 1143 -1144 , 1143f, 1149b ",
            "cite_spans": [
                {
                    "start": 1,
                    "end": 15,
                    "text": "Novastan, 1979",
                    "ref_id": null
                },
                {
                    "start": 16,
                    "end": 21,
                    "text": "-1980",
                    "ref_id": null
                },
                {
                    "start": 22,
                    "end": 51,
                    "text": ", 1979t-1980t NovoSeven, 1766",
                    "ref_id": null
                },
                {
                    "start": 52,
                    "end": 56,
                    "text": "2117",
                    "ref_id": null
                },
                {
                    "start": 57,
                    "end": 88,
                    "text": "Ruxolitinib, 865-866, 905, 1102",
                    "ref_id": null
                },
                {
                    "start": 89,
                    "end": 95,
                    "text": ", 1143",
                    "ref_id": null
                },
                {
                    "start": 96,
                    "end": 101,
                    "text": "-1144",
                    "ref_id": null
                },
                {
                    "start": 102,
                    "end": 116,
                    "text": ", 1143f, 1149b",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}